Name | Last modified | Size | Description | |
---|---|---|---|---|
Parent Directory | - | |||
value-transfers-of-c..> | 2024-06-26 09:06 | 96K | ||
methodological-note-..> | 2024-06-26 09:06 | 13K | ||
wp-file-manager-pro/ | 2024-05-15 17:00 | - | ||
cinfa-group-code-of-..> | 2024-03-20 15:14 | 1.5M | ||
PIL_Zinole-aripipraz..> | 2024-03-01 14:51 | 290K | ||
Methodological-note_..> | 2023-06-26 09:39 | 13K | ||
Cinfa_Value-Transfer..> | 2023-06-26 09:39 | 489K | ||
PIL_Coxicel-celecoxi..> | 2023-01-09 17:39 | 648K | ||
PIL_Olmepress-olmesa..> | 2023-01-09 09:57 | 112K | ||
PIL_Olmepress-Plus-o..> | 2022-12-29 13:16 | 389K | ||
PIL_Rosvacor-rosuvas..> | 2022-12-29 13:08 | 289K | ||
PIL_Doliact-tramadol..> | 2022-11-09 15:31 | 410K | ||
PIL_Zetmol-ezetimibe..> | 2022-11-08 15:22 | 183K | ||
PIL_Celoxol_PA-2.pdf | 2022-11-02 16:47 | 226K | ||
SPC_Celoxol_PA-2.pdf | 2022-11-02 16:47 | 509K | ||
PIL_Prelizat-pregaba..> | 2022-10-19 08:55 | 359K | ||
SPC_Prelizat-pregaba..> | 2022-10-19 08:55 | 641K | ||
PIL_Vanguard-plus-va..> | 2022-10-18 17:28 | 672K | ||
PIL_Prelizat-pregaba..> | 2022-10-18 17:20 | 385K | ||
SPC_Prelizat-pregaba..> | 2022-10-18 17:20 | 1.1M | ||
PIL_Ambroxol-Cinfa-a..> | 2022-10-18 17:07 | 48K | ||
SPC_Ambroxol-Cinfa-a..> | 2022-10-18 17:07 | 51K | ||
PIL_Sildenafilo-Cinf..> | 2022-10-18 17:00 | 150K | ||
SPC_Sildenafilo-Cinf..> | 2022-10-18 16:59 | 193K | ||
PIL_Respibien-oximet..> | 2022-10-06 15:36 | 63K | ||
SPC_Respibien-oximet..> | 2022-10-06 15:36 | 362K | ||
PIL_Cinfatos-Expect-..> | 2022-10-06 15:28 | 169K | ||
SPC_Cinfatos-Expect-..> | 2022-10-06 15:28 | 186K | ||
PIL_Reflizax-omepraz..> | 2022-09-06 10:35 | 433K | ||
PIL_Celoxol-celecoxi..> | 2022-09-05 16:33 | 211K | ||
PIL_Respibien-Oxymet..> | 2022-08-31 09:00 | 46K | ||
PIL_Co-Olmepress-olm..> | 2022-08-29 10:10 | 571K | ||
PIL_Olmepress-olmesa..> | 2022-08-26 10:36 | 270K | ||
PIL_Pharmagrip-Parac..> | 2022-08-26 09:43 | 157K | ||
PIL_Prelizat-pregaba..> | 2022-08-05 13:16 | 375K | ||
PIL_Rosuvastatina-Ci..> | 2022-08-01 12:11 | 274K | ||
SPC_Rosuvastatina-Ci..> | 2022-08-01 12:11 | 755K | ||
PIL_Co-Irbea-irbesar..> | 2022-08-01 10:57 | 732K | ||
PIL_Amlodipino-Cinfa..> | 2022-07-11 12:25 | 570K | ||
PIL_Paracetamol-Cinf..> | 2022-07-11 12:20 | 157K | ||
PIL_Olmepress-olmesa..> | 2022-07-08 12:56 | 272K | ||
Methodological-note_..> | 2022-06-28 08:13 | 13K | ||
Cinfa_Value-Transfer..> | 2022-06-28 08:13 | 173K | ||
PIL_Olmepress-olmesa..> | 2022-06-27 09:23 | 327K | ||
SPC_Olmepress-olmesa..> | 2022-06-27 09:22 | 263K | ||
PIL_Co-olmepress-olm..> | 2022-06-23 09:23 | 449K | ||
PIL_Irbea-Plus-irb_h..> | 2022-06-15 11:58 | 401K | ||
SPC_Irbea-Plus-irb_h..> | 2022-06-15 11:58 | 419K | ||
PIL_Celoxol_PA-1.pdf | 2022-06-15 11:46 | 226K | ||
SPC_Celoxol_PA-1.pdf | 2022-06-15 11:46 | 513K | ||
PIL_Rosuvastatina-Ci..> | 2022-06-08 16:30 | 520K | ||
SPC_Rosuvastatina-Ci..> | 2022-06-08 16:30 | 403K | ||
PIL_Prelizat-pregaba..> | 2022-06-08 16:15 | 433K | ||
SPC_Prelizat-pregaba..> | 2022-06-08 16:15 | 1.3M | ||
PIL_Loratadina-Cinfa..> | 2022-05-26 16:12 | 324K | ||
PIL_Fluconazol-Cinfa..> | 2022-05-20 12:30 | 266K | ||
SPC_Fluconazol-Cinfa..> | 2022-05-20 12:29 | 767K | ||
PIL_Irbea-irbesartan..> | 2022-05-18 13:33 | 362K | ||
SPC_Irbea-irbesartan..> | 2022-05-18 13:33 | 220K | ||
PIL_Amlodipino-Cinfa..> | 2022-05-17 17:04 | 164K | ||
SPC_Amlodipino-Cinfa..> | 2022-05-17 17:03 | 219K | ||
PIL_Doliact-Plus-hid..> | 2022-04-28 15:45 | 164K | ||
SPC_Doliact-Plus-hid..> | 2022-04-28 15:44 | 375K | ||
PIL_Prelizat-pregaba..> | 2022-04-20 15:03 | 443K | ||
PIL_Viruderm-Acyclov..> | 2022-03-30 17:13 | 151K | ||
PIL_Diclofenac-Cinfa..> | 2022-03-30 17:09 | 373K | ||
PIL_Atenolol-Cinfa-a..> | 2022-03-30 17:04 | 214K | ||
PIL_Prolatem-escital..> | 2022-03-21 16:48 | 251K | ||
PIL_Prelizat-pregaba..> | 2022-03-21 16:47 | 522K | ||
PIL_Nosadex-sertrali..> | 2022-03-21 16:45 | 539K | ||
PIL_Fluzax-fluconazo..> | 2022-03-21 16:44 | 268K | ||
PIL_Doliact-Plus-tra..> | 2022-03-21 16:42 | 242K | ||
PIL_Rosvacor-rosuvas..> | 2022-03-17 16:54 | 456K | ||
PIL_Reflizax-omepraz..> | 2022-03-17 16:54 | 453K | ||
PIL_Olanole-olanzapi..> | 2022-03-17 16:52 | 158K | ||
PIL_Maxerect-tadalaf..> | 2022-03-17 16:51 | 150K | ||
PIL_Irbea-Plus-irbes..> | 2022-03-17 16:50 | 345K | ||
PIL_Irbea-irbesartan..> | 2022-03-17 16:49 | 390K | ||
PIL_Ezmogard-esomepr..> | 2022-03-17 16:48 | 133K | ||
PIL_Doliact-tramadol..> | 2022-03-17 16:47 | 208K | ||
PIL_Cinfalair-Granul..> | 2022-03-17 16:45 | 187K | ||
PIL_Celoxol-celecoxi..> | 2022-03-17 16:44 | 299K | ||
PIL_Celoxol-celecoxi..> | 2022-03-17 16:43 | 299K | ||
PIL_Antimux-ambroxol..> | 2022-03-17 16:42 | 49K | ||
PIL_Co-Irbea-irbesar..> | 2022-03-17 16:39 | 657K | ||
PIL_Ziquin-levofloxa..> | 2022-03-17 15:53 | 283K | ||
PIL_Xflox-moxifloxac..> | 2022-03-17 15:52 | 513K | ||
PIL_Vanguard-plus-va..> | 2022-03-17 15:51 | 676K | ||
PIL_Ulcerbrex-rabepr..> | 2022-03-17 15:51 | 272K | ||
PIL_Co-Olmepress-olm..> | 2022-03-17 15:50 | 568K | ||
PIL_Atocor-atorvasta..> | 2022-03-17 15:48 | 496K | ||
PIL_Zinole-aripipraz..> | 2022-03-17 15:24 | 1.1M | ||
PIL_Lipizet-ezetimib..> | 2022-03-17 15:23 | 188K | ||
PIL_Levoact-levoflox..> | 2022-03-17 15:22 | 287K | ||
PIL_Lebalin-pregabal..> | 2022-03-17 15:21 | 536K | ||
PIL_Flomocin-moxiflo..> | 2022-03-17 15:19 | 518K | ||
PIL_Coxicel-celecoxi..> | 2022-03-17 15:18 | 291K | ||
PIL_Co-Olmepress-olm..> | 2022-03-17 15:17 | 468K | ||
PIL_Zetmol-ezetimibe..> | 2022-03-17 12:37 | 270K | ||
PIL_X-pert-D-vardena..> | 2022-03-17 12:34 | 270K | ||
PIL_X-pert-vardenafi..> | 2022-03-17 12:31 | 1.6M | ||
PIL_Vanguard-valsart..> | 2022-03-17 12:29 | 1.3M | ||
PIL_Readitic-tadalaf..> | 2022-03-17 12:22 | 241K | ||
PIL_Olmepress-olmesa..> | 2022-03-17 12:21 | 735K | ||
PIL_Olmedine-olmesar..> | 2022-03-17 12:18 | 713K | ||
PIL_Olanole-olanzapi..> | 2022-03-17 12:17 | 1.9M | ||
PIL_Lexaprim-escital..> | 2022-03-17 12:14 | 956K | ||
PIL_Irbea-irbesartan..> | 2022-03-17 12:10 | 414K | ||
PIL_Deslarex-deslora..> | 2022-03-17 12:09 | 1.4M | ||
PIL_Coxicel-celecoxi..> | 2022-03-17 12:08 | 426K | ||
PIL_Convolt-levetira..> | 2022-03-17 12:05 | 1.1M | ||
PIL_Cinfaletro-monte..> | 2022-03-17 11:44 | 1.7M | ||
PIL_Cinfalair-P-mont..> | 2022-03-17 11:42 | 1.9M | ||
PIL_Cinfalair-CT-mon..> | 2022-03-17 11:41 | 1.9M | ||
PIL_Cinfalair-montel..> | 2022-03-17 11:36 | 1.8M | ||
PIL_Cinfahelix-heder..> | 2022-03-17 11:35 | 953K | ||
PIL_Olmidip-olmesart..> | 2022-03-17 11:31 | 810K | ||
PIL_Olmidip-olmesart..> | 2022-03-17 10:19 | 810K | ||
PIL_Olmepress-olmesa..> | 2022-03-17 10:17 | 1.1M | ||
PIL_Olmepress-Plus-o..> | 2022-03-16 17:41 | 441K | ||
SPC_Olmepress-Plus-o..> | 2022-03-16 17:41 | 1.4M | ||
PIL_Escitalax-escita..> | 2022-03-16 11:12 | 1.3M | ||
PIL_Devarin-ODT-vard..> | 2022-03-16 11:07 | 176K | ||
PIL_Devarin-vardenaf..> | 2022-03-16 11:06 | 1.6M | ||
PIL_Destamin-deslora..> | 2022-03-16 11:06 | 1.4M | ||
PIL_Maxerect-tadalaf..> | 2022-03-15 17:57 | 304K | ||
SPC_Maxerect-tadalaf..> | 2022-03-15 17:56 | 338K | ||
PIL_Tadyna-trimetazi..> | 2022-03-15 17:01 | 147K | ||
SPC_Tadyna-trimetazi..> | 2022-03-15 17:01 | 180K | ||
PIL_Sildenafilo-Cinf..> | 2022-03-15 16:59 | 148K | ||
SPC_Sildenafilo-Cinf..> | 2022-03-15 16:59 | 198K | ||
PIL_Rosvacor-rosuvas..> | 2022-03-15 16:58 | 380K | ||
SPC_Rosvacor-rosuvas..> | 2022-03-15 16:58 | 403K | ||
PIL_Rosuvastatina-Ci..> | 2022-03-15 16:56 | 428K | ||
SPC_Rosuvastatina-Ci..> | 2022-03-15 16:56 | 406K | ||
PIL_Gablix-pregabali..> | 2022-03-15 16:55 | 199K | ||
SPC_Gablix-pregabali..> | 2022-03-15 16:54 | 815K | ||
PIL_Prelizat-pregaba..> | 2022-03-15 16:53 | 341K | ||
SPC_Prelizat-pregaba..> | 2022-03-15 16:53 | 404K | ||
PIL_Omeprazol-Cinfa-..> | 2022-03-15 16:52 | 275K | ||
SPC_Omeprazol-Cinfa-..> | 2022-03-15 16:52 | 552K | ||
PIL_Olmepressam-olme..> | 2022-03-15 16:49 | 303K | ||
SPC_Olmepressam-olme..> | 2022-03-15 16:49 | 319K | ||
PIL_Olmepress-olmesa..> | 2022-03-15 16:47 | 365K | ||
SPC_Olmepress-olmesa..> | 2022-03-15 16:47 | 349K | ||
PIL_Loratadina-Cinfa..> | 2022-03-15 15:41 | 158K | ||
SPC_Loratadina-Cinfa..> | 2022-03-15 15:40 | 164K | ||
PIL_Lisinopril-Cinfa..> | 2022-03-15 15:39 | 203K | ||
SPC_Lisinopril-Cinfa..> | 2022-03-15 15:39 | 294K | ||
PIL_Irbesartan-Cinfa..> | 2022-03-15 15:38 | 363K | ||
SPC_Irbesartan-Cinfa..> | 2022-03-15 15:38 | 224K | ||
PIL_Irbea-Plus-irb_h..> | 2022-03-15 15:36 | 386K | ||
SPC_Irbea-Plus-irb_h..> | 2022-03-15 15:36 | 417K | ||
PIL_Irbea-irbesartan..> | 2022-03-15 15:35 | 222K | ||
SPC_Irbea-irbesartan..> | 2022-03-15 15:35 | 117K | ||
PIL_Furosemida-Cinfa..> | 2022-03-15 15:34 | 217K | ||
SPC_Furosemida-Cinfa..> | 2022-03-15 15:33 | 357K | ||
PIL_Fluconazol-Cinfa..> | 2022-03-15 15:32 | 265K | ||
SPC_Fluconazol-Cinfa..> | 2022-03-15 15:32 | 772K | ||
PIL_Enalapril-Cinfa-..> | 2022-03-15 15:30 | 182K | ||
SPC_Enalapril-Cinfa-..> | 2022-03-15 15:30 | 468K | ||
PIL_Arxia_Dolxib-eto..> | 2022-03-15 15:28 | 245K | ||
SPC_Arxia_Dolxib-eto..> | 2022-03-15 15:28 | 437K | ||
PIL_Tramazetan-Plus-..> | 2022-03-15 15:26 | 158K | ||
SPC_Tramazetan-Plus-..> | 2022-03-15 15:26 | 364K | ||
PIL_Deflazacort-Cinf..> | 2022-03-15 15:24 | 174K | ||
SPC_Deflazacort-Cinf..> | 2022-03-15 15:24 | 152K | ||
PIL_Clopidogrel-Cinf..> | 2022-03-15 15:23 | 405K | ||
SPC_Clopidogrel-Cinf..> | 2022-03-15 15:22 | 514K | ||
PIL_Ciprofloxacino-C..> | 2022-03-15 15:21 | 217K | ||
SPC_Ciprofloxacino-C..> | 2022-03-15 15:21 | 386K | ||
PIL_Cinfatos-Expect-..> | 2022-03-15 15:20 | 429K | ||
SPC_Cinfatos-Expect-..> | 2022-03-15 15:20 | 195K | ||
PIL_Celoxol_PA.pdf | 2022-03-15 15:19 | 224K | ||
SPC_Celoxol_PA.pdf | 2022-03-15 15:19 | 509K | ||
PIL_Captopril-Cinfa_..> | 2022-03-15 15:17 | 173K | ||
SPC_Captopril-Cinfa_..> | 2022-03-15 15:17 | 247K | ||
PIL_Candesartan-Cinf..> | 2022-03-15 15:16 | 248K | ||
SPC_Candesartan-Cinf..> | 2022-03-15 15:15 | 255K | ||
PIL_Calmaprox-dexket..> | 2022-03-15 15:14 | 153K | ||
SPC_Calmaprox-dexket..> | 2022-03-15 15:14 | 280K | ||
PIL_Azitromicina-Cin..> | 2022-03-15 15:12 | 191K | ||
SPC_Azitromicina-Cin..> | 2022-03-15 15:12 | 234K | ||
PIL_Atenolol-Cinfa-a..> | 2022-03-15 15:11 | 319K | ||
SPC_Atenolol-Cinfa-a..> | 2022-03-15 15:11 | 168K | ||
PIL_Amlodipino-Cinfa..> | 2022-03-15 15:10 | 163K | ||
SPC_Amlodipino-Cinfa..> | 2022-03-15 15:09 | 219K | ||
PIL_Ambroxol-Cinfa-a..> | 2022-03-15 15:08 | 39K | ||
SPC_Ambroxol-Cinfa-a..> | 2022-03-15 15:08 | 178K | ||
PIL_Ranitidina-Cinfa..> | 2022-03-15 12:05 | 512K | ||
PIL_Ziquin-levofloxa..> | 2022-03-09 18:10 | 280K | ||
PIL_Xflox-Moxifloxac..> | 2022-03-09 18:09 | 511K | ||
PIL_Ulcerbrex-Rabepr..> | 2022-03-09 18:07 | 272K | ||
PIL_Rybox-Etoricoxib..> | 2022-03-09 18:06 | 446K | ||
PIL_Olmepress-olmesa..> | 2022-03-09 18:05 | 1.1M | ||
PIL_Deslarex-deslora..> | 2022-03-09 17:50 | 1.4M | ||
PIL_Deslarex-deslora..> | 2022-03-09 17:47 | 1.4M | ||
PIL_Olmedine-olmesar..> | 2022-03-09 17:47 | 708K | ||
PIL_Coxicel-celecoxi..> | 2022-03-09 17:46 | 525K | ||
PIL_Co-Olmepress-mon..> | 2022-03-09 17:44 | 560K | ||
PIL_Cinfalair-P-Gran..> | 2022-03-09 17:43 | 1.9M | ||
PIL_Cinfalair-chewab..> | 2022-03-09 17:42 | 1.9M | ||
PIL_Cinfalair-montel..> | 2022-03-09 17:32 | 1.8M | ||
PIL_Atorcor-Atorvast..> | 2022-03-09 17:30 | 489K | ||
PIL_Ziquin-levofloxa..> | 2022-03-09 16:36 | 281K | ||
PIL_Zetmol-ezetimibe..> | 2022-03-09 16:34 | 182K | ||
PIL_X-pert-vardernaf..> | 2022-03-09 16:33 | 1.6M | ||
PIL_Xflox-Moxifloxac..> | 2022-03-09 16:31 | 511K | ||
PIL_Ulcerbrex-Rabepr..> | 2022-03-09 16:31 | 272K | ||
PIL_Coxicel-celecoxi..> | 2022-03-09 16:28 | 456K | ||
PIL_Co-olmepress-olm..> | 2022-03-09 16:27 | 444K | ||
PIL_Cinfalair-P-mont..> | 2022-03-09 16:25 | 283K | ||
PIL_Cinfalair-CT-mon..> | 2022-03-09 16:21 | 523K | ||
PIL_Cinfalair-montel..> | 2022-03-09 16:12 | 258K | ||
PIL_Paracetamol-Cinf..> | 2022-03-09 15:58 | 148K | ||
PIL_Finasterida-Cinf..> | 2022-03-09 15:57 | 466K | ||
PIL_Ketoconazol-Cinf..> | 2022-03-09 15:55 | 372K | ||
PIL_Neosayomol-Diphe..> | 2022-03-09 15:53 | 65K | ||
PIL_Viruderm-Acyclov..> | 2022-03-09 15:38 | 150K | ||
PIL_Respibien-Oxymet..> | 2022-03-09 15:36 | 46K | ||
PIL_Piroxicam-Cinfa-..> | 2022-03-09 15:36 | 213K | ||
PIL_Pharmagrip-Parac..> | 2022-03-09 15:34 | 156K | ||
PIL_Paracetamol-Cinf..> | 2022-03-09 15:33 | 144K | ||
PIL_Paracetamol-Cinf..> | 2022-03-09 15:32 | 157K | ||
PIL_Neosayomol-Cream..> | 2022-03-09 15:29 | 61K | ||
PIL_Meloxicam-Cinfa-..> | 2022-03-09 15:27 | 444K | ||
PIL_Loratadina-Cinfa..> | 2022-03-09 15:26 | 323K | ||
PIL_Gastribien-Antia..> | 2022-03-09 15:25 | 264K | ||
PIL_Loratadina-Cinfa..> | 2022-03-09 15:22 | 323K | ||
PIL_Ketoconazol-Cinf..> | 2022-03-09 15:21 | 368K | ||
PIL_Ibufen-ibuprofen..> | 2022-03-09 15:20 | 134K | ||
PIL_Famotidina-Cinfa..> | 2022-03-09 15:19 | 428K | ||
PIL_Famotidina-Cinfa..> | 2022-03-09 15:16 | 428K | ||
PIL_Diclofenac-Cinfa..> | 2022-03-09 15:15 | 213K | ||
PIL_Cinfadol-Diclofe..> | 2022-03-09 15:13 | 154K | ||
PIL_Ciprofloxacino-C..> | 2022-03-09 15:07 | 517K | ||
PIL_Cinfatos-Complex..> | 2022-03-09 15:06 | 172K | ||
PIL_Cinfamar-Caffein..> | 2022-03-09 15:04 | 145K | ||
PIL_Cinfamar-Coated-..> | 2022-03-09 15:02 | 331K | ||
PIL_Atenolol-Cinfa-a..> | 2022-03-09 14:59 | 229K | ||
PIL_Antihemorroidal-..> | 2022-03-09 14:48 | 118K | ||
PIL_AMLODIPINO-CINFA..> | 2022-03-09 14:47 | 569K | ||
PIL_AMBROXOL-CINFA_A..> | 2022-03-09 14:45 | 321K | ||
PIL_AMBROXOL-CINFA_A..> | 2022-03-09 14:36 | 321K | ||
Cinfa_Value_transfer..> | 2021-06-28 12:18 | 138K | ||
Methodological_note_..> | 2021-06-28 12:18 | 13K | ||
PIL_Olmepress-olmesa..> | 2021-06-21 18:38 | 1.1M | ||
header-care-539x300.jpg | 2021-06-14 08:00 | 26K | ||
header-care-700x111.jpg | 2021-06-14 08:00 | 15K | ||
header-care-1000x300..> | 2021-06-14 08:00 | 51K | ||
header-care-500x300.jpg | 2021-06-14 08:00 | 25K | ||
header-care-400x260.jpg | 2021-06-14 08:00 | 18K | ||
header-care-345x198.jpg | 2021-06-14 08:00 | 13K | ||
header-care-800x300.jpg | 2021-06-14 08:00 | 35K | ||
header-care-600x300.jpg | 2021-06-14 08:00 | 28K | ||
header-care-570x300.jpg | 2021-06-14 08:00 | 27K | ||
header-care-1536x243..> | 2021-06-14 08:00 | 52K | ||
header-care-768x121.jpg | 2021-06-14 08:00 | 18K | ||
header-care-150x150.jpg | 2021-06-14 08:00 | 5.9K | ||
header-care-1024x162..> | 2021-06-14 08:00 | 28K | ||
header-care-300x47.jpg | 2021-06-14 08:00 | 4.4K | ||
header-care.jpg | 2021-06-14 08:00 | 100K | ||
header-mobiity-539x3..> | 2021-06-14 07:56 | 23K | ||
header-mobiity-700x1..> | 2021-06-14 07:56 | 17K | ||
header-mobiity-1000x..> | 2021-06-14 07:56 | 40K | ||
header-mobiity-500x3..> | 2021-06-14 07:56 | 22K | ||
header-mobiity-400x2..> | 2021-06-14 07:56 | 15K | ||
header-mobiity-345x1..> | 2021-06-14 07:56 | 12K | ||
header-mobiity-800x3..> | 2021-06-14 07:56 | 32K | ||
header-mobiity-600x3..> | 2021-06-14 07:56 | 26K | ||
header-mobiity-570x3..> | 2021-06-14 07:56 | 24K | ||
header-mobiity-1536x..> | 2021-06-14 07:56 | 52K | ||
header-mobiity-768x1..> | 2021-06-14 07:56 | 19K | ||
header-mobiity-150x1..> | 2021-06-14 07:56 | 5.4K | ||
header-mobiity-1024x..> | 2021-06-14 07:56 | 30K | ||
header-mobiity-300x4..> | 2021-06-14 07:56 | 4.9K | ||
header-mobiity.jpg | 2021-06-14 07:56 | 89K | ||
header-naturals-539x..> | 2021-06-14 07:53 | 35K | ||
header-naturals-700x..> | 2021-06-14 07:53 | 14K | ||
header-naturals-1000..> | 2021-06-14 07:53 | 56K | ||
header-naturals-500x..> | 2021-06-14 07:53 | 33K | ||
header-naturals-400x..> | 2021-06-14 07:53 | 23K | ||
header-naturals-345x..> | 2021-06-14 07:53 | 16K | ||
header-naturals-800x..> | 2021-06-14 07:53 | 46K | ||
header-naturals-600x..> | 2021-06-14 07:53 | 37K | ||
header-naturals-570x..> | 2021-06-14 07:53 | 35K | ||
header-naturals-1536..> | 2021-06-14 07:53 | 46K | ||
header-naturals-768x..> | 2021-06-14 07:53 | 16K | ||
header-naturals-150x..> | 2021-06-14 07:53 | 8.2K | ||
header-naturals-1024..> | 2021-06-14 07:53 | 25K | ||
header-naturals-300x..> | 2021-06-14 07:53 | 4.1K | ||
header-naturals.jpg | 2021-06-14 07:53 | 84K | ||
header-non-pres-drug..> | 2021-06-14 07:48 | 29K | ||
header-non-pres-drug..> | 2021-06-14 07:48 | 21K | ||
header-non-pres-drug..> | 2021-06-14 07:48 | 53K | ||
header-non-pres-drug..> | 2021-06-14 07:48 | 26K | ||
header-non-pres-drug..> | 2021-06-14 07:48 | 17K | ||
header-non-pres-drug..> | 2021-06-14 07:48 | 14K | ||
header-non-pres-drug..> | 2021-06-14 07:48 | 44K | ||
header-non-pres-drug..> | 2021-06-14 07:48 | 34K | ||
header-non-pres-drug..> | 2021-06-14 07:48 | 32K | ||
header-non-pres-drug..> | 2021-06-14 07:48 | 69K | ||
header-non-pres-drug..> | 2021-06-14 07:48 | 25K | ||
header-non-pres-drug..> | 2021-06-14 07:48 | 4.9K | ||
header-non-pres-drug..> | 2021-06-14 07:48 | 39K | ||
header-non-pres-drug..> | 2021-06-14 07:48 | 5.7K | ||
header-non-pres-drug..> | 2021-06-14 07:48 | 136K | ||
PIL_Ziquin-levofloxa..> | 2021-06-09 12:03 | 214K | ||
PIL_Co-Irbea-irbesar..> | 2021-06-08 12:08 | 462K | ||
PIL_Xflox-moxifloxac..> | 2021-05-27 15:09 | 329K | ||
PIL_Coxicel-Celecoxi..> | 2021-05-27 12:50 | 301K | ||
PIL_Ziquin-levofloxa..> | 2021-05-25 12:36 | 214K | ||
PIL_Ibufen_HK-1.pdf | 2021-05-11 13:05 | 98K | ||
PIL_Piroxicam_HK-1.pdf | 2021-05-11 12:54 | 160K | ||
PIL_Cinfamar-Caffein..> | 2021-05-11 12:37 | 109K | ||
PIL_Cinfamar-dimenhy..> | 2021-05-11 12:11 | 195K | ||
PIL_Xflox-moxifloxac..> | 2021-05-07 10:47 | 347K | ||
PIL_Cinfalair-montel..> | 2021-05-06 15:13 | 284K | ||
PIL_Cinfalair-montel..> | 2021-05-05 14:14 | 259K | ||
PIL_Cinfalair-montel..> | 2021-05-05 14:09 | 524K | ||
PIL_Azitromicina-azi..> | 2021-04-19 14:08 | 154K | ||
FT_Azitromicina-azit..> | 2021-04-19 14:08 | 200K | ||
PIL_Vanguard-Plus-va..> | 2021-04-16 10:43 | 123K | ||
PIL_Vanguard-valsart..> | 2021-04-16 10:14 | 1.0M | ||
PIL_Irbea-Plus-irbes..> | 2021-04-14 11:12 | 185K | ||
FT_Irbea-Plus-irbesa..> | 2021-04-14 11:12 | 283K | ||
PIL_Deflazacort-Cinf..> | 2021-04-14 11:04 | 140K | ||
FT_Deflazacort-Cinfa..> | 2021-04-14 11:04 | 116K | ||
PIL_Fluzax-fluconazo..> | 2021-03-30 15:26 | 482K | ||
SPC_Candesartan-Cinf..> | 2021-03-05 12:14 | 354K | ||
PIL_Candesartan-Cinf..> | 2021-03-05 12:14 | 237K | ||
PIL_Rosuvastatina-ci..> | 2021-03-05 12:13 | 425K | ||
SPC_Rosuvastatina-ci..> | 2021-03-05 12:13 | 407K | ||
PIL_Rosuvastatina-ci..> | 2021-02-25 16:16 | 425K | ||
PIL_Rosuvastatina-ci..> | 2021-02-25 15:12 | 421K | ||
SPC_Rosuvastatina-ci..> | 2021-02-25 15:12 | 407K | ||
PIL_Co-Olmepress-olm..> | 2021-02-19 13:21 | 359K | ||
PIL_Olmepress-olmesa..> | 2021-02-05 13:36 | 198K | ||
SPC_Olmepress-olmesa..> | 2021-02-05 13:36 | 281K | ||
PIL_Olmepress-Plus-o..> | 2021-02-05 12:18 | 241K | ||
SPC_Olmepress-Plus-o..> | 2021-02-05 12:18 | 562K | ||
PIL_Maxerect-tadalaf..> | 2021-02-05 08:45 | 111K | ||
SPC_Maxerect-tadalaf..> | 2021-02-05 08:45 | 178K | ||
PIL_Cinfahelix-heder..> | 2021-01-29 10:28 | 1.5M | ||
PIL_Co-Olmepress-olm..> | 2021-01-21 13:10 | 350K | ||
PIL_Rosvacor-rosuvas..> | 2021-01-21 11:18 | 336K | ||
PIL_Nosadex-sertrali..> | 2021-01-21 09:44 | 272K | ||
PIL_Devarin-vardenaf..> | 2021-01-12 11:49 | 199K | ||
aioseo-logs/ | 2020-12-22 08:06 | - | ||
PIL_Flomocin-Moxiflo..> | 2020-12-11 11:22 | 335K | ||
PIL_Co-Olmepress-olm..> | 2020-12-11 10:51 | 351K | ||
PIL_Devarin-vardenaf..> | 2020-12-01 10:18 | 276K | ||
PIL_X-pert-D-vardena..> | 2020-11-19 14:07 | 145K | ||
PIL_X-pert-vardenafi..> | 2020-11-19 13:54 | 143K | ||
PIL_Devarin-vardenaf..> | 2020-11-16 13:38 | 139K | ||
PIL_Viruderm-Ointmen..> | 2020-11-11 10:24 | 114K | ||
PIL_Cinfatos-Complex..> | 2020-11-09 15:02 | 136K | ||
PIL_Cinfadol-Ibuprof..> | 2020-11-09 14:31 | 119K | ||
PIL_Paracetamol-Cinf..> | 2020-11-09 13:14 | 150K | ||
PIL_Maxerect-tadalaf..> | 2020-11-05 16:14 | 209K | ||
PIL_Xflox-moxifloxac..> | 2020-10-27 09:12 | 329K | ||
PIL_Escitalax-escita..> | 2020-10-22 11:35 | 408K | ||
PIL_Celecoxib-celeco..> | 2020-10-22 10:18 | 230K | ||
PIL_Lipizet-ezetimib..> | 2020-10-15 11:23 | 149K | ||
complianz/ | 2020-10-15 10:43 | - | ||
PIL_Olmepress-olmesa..> | 2020-10-14 14:10 | 207K | ||
PIL_Omeprazol-Cinfa-..> | 2020-09-29 09:17 | 255K | ||
PIL_Ranitidina-Cinfa..> | 2020-09-28 11:47 | 237K | ||
PIL_Omeprazol-Cinfa-..> | 2020-09-28 10:55 | 254K | ||
PIL_Cinfahelix-heder..> | 2020-09-21 15:17 | 66K | ||
PIL_Zetmol-ezetimibe..> | 2020-09-18 13:07 | 145K | ||
PIL_Rybox-etoricoxib..> | 2020-09-16 11:39 | 335K | ||
PIL_Lipizet-ezetimib..> | 2020-09-15 13:23 | 148K | ||
PIL_Ziquin-levofloxa..> | 2020-09-11 14:49 | 211K | ||
PIL_Cinfalair-Paedia..> | 2020-09-11 14:23 | 141K | ||
PIL_Cinfalair-Paedia..> | 2020-09-11 14:22 | 141K | ||
PIL_Cinfalair-montel..> | 2020-09-11 14:14 | 143K | ||
PIL_Cinfalair-montel..> | 2020-09-11 14:13 | 143K | ||
PIL_Ziquin-levofloxa..> | 2020-09-11 13:33 | 214K | ||
PIL_Diclofenac-Cinfa..> | 2020-09-10 11:49 | 177K | ||
PIL_Clopidogrel-Cinf..> | 2020-09-10 11:07 | 255K | ||
SPC_Clopidogrel-Cinf..> | 2020-09-10 11:07 | 385K | ||
PIL_Xflox-Moxifloxac..> | 2020-08-31 09:06 | 331K | ||
PIL_Cinfalair-montel..> | 2020-08-26 14:27 | 143K | ||
PIL_Respibien-oximet..> | 2020-07-31 09:05 | 123K | ||
SPC_Respibien-oximet..> | 2020-07-31 09:04 | 123K | ||
PIL_Respibien-oximet..> | 2020-07-31 09:04 | 123K | ||
PIL_Cinfatos-Complex..> | 2020-07-23 14:22 | 212K | ||
PIL_Irbea-irbesartan..> | 2020-07-23 13:00 | 300K | ||
PIL_Paracetamol-Cinf..> | 2020-07-23 12:18 | 252K | ||
PIL_Atocor-atorvasta..> | 2020-07-16 10:30 | 367K | ||
PIL_Co-Irbea-irbesar..> | 2020-07-14 13:44 | 279K | ||
PIL_Ziquin-levofloxa..> | 2020-07-09 10:42 | 209K | ||
PIL_Ziquin-levofloxa..> | 2020-07-03 14:55 | 214K | ||
PIL_Xflox-moxifloxac..> | 2020-07-03 14:37 | 317K | ||
PIL_Meloxicam-Cinfa_..> | 2020-07-03 14:00 | 278K | ||
PIL_Fluconazol-Cinfa..> | 2020-07-01 15:45 | 142K | ||
PIL_Paracetamol-Cinf..> | 2020-07-01 15:07 | 225K | ||
PIL_Respibien-Oxymet..> | 2020-06-30 16:48 | 123K | ||
PIL_Cinfadol-Ibuprof..> | 2020-06-30 15:51 | 99K | ||
PIL_Diclofenaco-Cinf..> | 2020-06-30 12:48 | 177K | ||
SPC_Diclofenaco-Cinf..> | 2020-06-30 12:47 | 295K | ||
PIL_Cinfalair-montel..> | 2020-06-30 11:50 | 198K | ||
PIL_Tramadol-Cinfa-t..> | 2020-06-29 16:32 | 314K | ||
PIL_Amlodipino-Cinfa..> | 2020-06-29 16:09 | 240K | ||
PIL_Pharmagrip-Capsu..> | 2020-06-29 13:15 | 121K | ||
PIL_Paracetamol-Cinf..> | 2020-06-29 12:50 | 121K | ||
PIL_Flomocin-Moxiflo..> | 2020-06-29 11:05 | 287K | ||
PIL_Cinfalair-montel..> | 2020-06-29 10:25 | 194K | ||
2017-Value-Transfers..> | 2020-06-26 15:27 | 194K | ||
2017-Note-Methodolog..> | 2020-06-26 15:27 | 79K | ||
2019-Value-Transfers..> | 2020-06-26 15:27 | 336K | ||
2019-Note-Methodolog..> | 2020-06-26 15:27 | 13K | ||
2018-Value-Transfers..> | 2020-06-26 15:27 | 40K | ||
2018-Note-Methodolog..> | 2020-06-26 15:27 | 29K | ||
PIL_Xflox-moxifloxac..> | 2020-06-26 11:14 | 247K | ||
Methodological-note_..> | 2020-06-26 10:30 | 13K | ||
Cinfa-value-transfer..> | 2020-06-26 10:30 | 336K | ||
PIL_Ciprofloxacino-c..> | 2020-06-25 11:19 | 261K | ||
PIL_Cinfalair-montel..> | 2020-06-25 09:57 | 194K | ||
SPC_Rosuvastatina_PA..> | 2020-06-23 12:20 | 519K | ||
PIL_Rosuvastatina_PA..> | 2020-06-23 12:20 | 403K | ||
PIL_Omeprazol-Cinfa-..> | 2020-06-22 16:48 | 208K | ||
SPC_Omeprazol-Cinfa-..> | 2020-06-22 16:48 | 378K | ||
PIL_Ulcerbrex-rabepr..> | 2020-06-22 16:20 | 89K | ||
PIL_Ulcerbrex-rabepr..> | 2020-06-22 16:01 | 203K | ||
PIL_Tramadol-tramado..> | 2020-06-19 14:52 | 162K | ||
SPC_Tramadol-tramado..> | 2020-06-19 14:51 | 201K | ||
PIL_Olmepress-olmesa..> | 2020-06-19 13:18 | 221K | ||
PIL_Atorcor-atorvast..> | 2020-06-17 13:00 | 368K | ||
PIL_Cinfatos-Expecto..> | 2020-06-17 12:10 | 271K | ||
SPC_Cinfatos-Expecto..> | 2020-06-17 12:10 | 158K | ||
PIL_Tadyna-trimetazi..> | 2020-06-16 18:25 | 110K | ||
SPC_Tadyna-trimetazi..> | 2020-06-16 18:25 | 143K | ||
PIL_Irbea-irbesartan..> | 2020-06-16 18:19 | 185K | ||
SPC_Irbea-irbesartan..> | 2020-06-16 18:19 | 226K | ||
PIL_Escitalax-escita..> | 2020-06-12 08:29 | 286K | ||
PIL_Devarin-vardenaf..> | 2020-06-12 08:19 | 275K | ||
PIL_co-olmepress-olm..> | 2020-06-11 16:56 | 440K | ||
PL_atorvastatina-4.pdf | 2020-06-10 16:16 | 94K | ||
SPC_atorvastatina-4.pdf | 2020-06-10 16:15 | 332K | ||
PIL_Readitic-taladaf..> | 2020-06-10 11:31 | 186K | ||
PIL_Olmedine-olmesar..> | 2020-06-10 11:28 | 482K | ||
PIL_Co-Olmepress-olm..> | 2020-06-10 11:26 | 360K | ||
PIL_Olmedine-olmesar..> | 2020-06-10 11:24 | 480K | ||
PIL_Co-Olmepress-olm..> | 2020-06-10 11:21 | 360K | ||
PIL_Olmepress-olmesa..> | 2020-06-10 11:17 | 206K | ||
PL_cinfalair-montelu..> | 2020-01-02 10:47 | 545K | ||
PIL_irbesartan-compr..> | 2019-12-31 12:50 | 174K | ||
SPC_irbesartan-compr..> | 2019-12-31 12:50 | 265K | ||
PIL_atenolol_HK-1.pdf | 2019-11-15 11:34 | 161K | ||
Cinfa-Groups-Code-of..> | 2019-11-07 08:26 | 1.3M | ||
PIPELINE-October-201..> | 2019-10-30 13:21 | 175K | ||
PIL_paracetamol_MO.pdf | 2019-10-25 08:52 | 64K | ||
PIL_Neosayomol_MO.pdf | 2019-10-25 08:52 | 45K | ||
PIL_Deslarex-deslora..> | 2019-10-24 15:20 | 60K | ||
PIL_Destamin-deslora..> | 2019-10-24 15:10 | 58K | ||
PIL_Deslarex-deslora..> | 2019-10-24 15:08 | 56K | ||
PIL_Deslarex-deslora..> | 2019-10-24 15:06 | 56K | ||
PIPELINE-October-201..> | 2019-10-21 15:27 | 175K | ||
PL_lexaprim-escitalo..> | 2019-10-10 12:49 | 193K | ||
PIL_atorcor_QA-1.pdf | 2019-10-10 12:29 | 166K | ||
PIL_ziquin-levofloxa..> | 2019-10-10 12:09 | 70K | ||
PIL_ziquin-levofloxa..> | 2019-10-10 12:06 | 70K | ||
PL_Furosemida-compri..> | 2019-09-26 14:20 | 63K | ||
SPC_Furosemida-compr..> | 2019-09-26 14:20 | 115K | ||
PIL_Cinfalair-Film-C..> | 2019-09-25 12:38 | 61K | ||
PIL-Co-Irbea_KW-1.pdf | 2019-08-14 15:13 | 133K | ||
PIL-Co-Irbea_KW.pdf | 2019-08-14 15:09 | 224K | ||
PIL_xflox-moxifloxac..> | 2019-08-14 14:59 | 107K | ||
innova-mostrador-539..> | 2019-07-29 13:32 | 25K | ||
innova-mostrador-500..> | 2019-07-29 13:32 | 27K | ||
innova-mostrador-400..> | 2019-07-29 13:32 | 18K | ||
innova-mostrador-345..> | 2019-07-29 13:32 | 14K | ||
innova-mostrador-600..> | 2019-07-29 13:32 | 32K | ||
innova-mostrador-570..> | 2019-07-29 13:32 | 30K | ||
innova-mostrador-300..> | 2019-07-29 13:32 | 12K | ||
innova-mostrador-150..> | 2019-07-29 13:32 | 5.9K | ||
innova-mostrador.jpg | 2019-07-29 13:32 | 39K | ||
PIL-lansoprazo_PA.pdf | 2019-07-19 11:57 | 38K | ||
SPC-lansoprazol_PA.pdf | 2019-07-19 11:57 | 118K | ||
PL_Amlodipino-cinfa_..> | 2019-06-24 12:04 | 75K | ||
SPC_Amlodipino-cinfa..> | 2019-06-24 12:03 | 114K | ||
Value_Transfers_Of_C..> | 2019-06-14 11:18 | 40K | ||
Methodological_Note_..> | 2019-06-14 11:18 | 29K | ||
PIL_Ranitidina_HK-2.pdf | 2019-06-10 11:10 | 73K | ||
PIL_Ranitidina_HK-1.pdf | 2019-06-10 11:09 | 73K | ||
PIL-Ciprofloxacin_HK..> | 2019-06-10 10:35 | 127K | ||
PIL-Ciprofloxacin_HK..> | 2019-06-10 10:33 | 127K | ||
PIL-Ciprofloxacin_HK..> | 2019-06-10 10:31 | 127K | ||
PIL-Irbea-Irbesartan..> | 2019-06-04 17:28 | 242K | ||
PIL_ziquin-levofloxa..> | 2019-06-04 17:08 | 95K | ||
PIL-Xflox-moxifloxac..> | 2019-06-04 17:01 | 107K | ||
Safety-Communication..> | 2019-05-14 15:24 | 312K | ||
PL_Cinfatos-Expector..> | 2019-05-09 14:44 | 53K | ||
SPC_Cinfatos-Expecto..> | 2019-05-09 14:43 | 94K | ||
PIL_Bucomax_MO-1.pdf | 2019-05-02 13:15 | 91K | ||
PIL_Bucomax_MO.pdf | 2019-05-02 13:13 | 87K | ||
PIL_Finasteride_MO.pdf | 2019-05-02 13:04 | 72K | ||
PIL_Flomocin_KSA.pdf | 2019-04-30 10:29 | 79K | ||
PIL_Cinfamar-Caffein..> | 2019-04-26 09:31 | 26K | ||
PIL_Cinfamar_HK.pdf | 2019-04-26 09:25 | 39K | ||
PIL_Tisuderma_HK.pdf | 2019-04-25 12:35 | 22K | ||
PIL_Respibien_HK.pdf | 2019-04-25 12:30 | 45K | ||
PIL_Piroxicam_HK.pdf | 2019-04-25 12:25 | 35K | ||
PIL_Viruderm_HK.pdf | 2019-04-25 12:05 | 19K | ||
PIL_Tramadol_HK.pdf | 2019-04-25 11:58 | 56K | ||
PIL_Ranitidina_HK.pdf | 2019-04-25 11:45 | 30K | ||
PIL_Pharmagrip-capsu..> | 2019-04-25 11:35 | 50K | ||
PIL_Paracetamol650mg..> | 2019-04-25 11:29 | 42K | ||
PIL_Paracetamol-1g_H..> | 2019-04-25 11:21 | 36K | ||
PIL_Azitromicina_PA-..> | 2019-04-25 10:51 | 57K | ||
FT_Azitromicina_PA-1..> | 2019-04-25 10:51 | 129K | ||
PIL_Azitromicina_PA.pdf | 2019-04-25 10:47 | 57K | ||
FT_Azitromicina_PA.pdf | 2019-04-25 10:47 | 129K | ||
PIL_Neosayomol_HK.pdf | 2019-04-24 16:46 | 35K | ||
PIL_meloxicam_HK.pdf | 2019-04-24 16:39 | 85K | ||
PIL_Loratadina-Table..> | 2019-04-24 14:52 | 41K | ||
PIL_gastribien_HK.pdf | 2019-04-24 14:44 | 30K | ||
PIL_Antihemorroidal-..> | 2019-04-24 14:42 | 19K | ||
PIL_Antihemorroidal-..> | 2019-04-24 14:39 | 19K | ||
PIL_Ketoconazol_HK.pdf | 2019-04-16 16:44 | 57K | ||
PIL_Ibufen_HK.pdf | 2019-04-16 16:34 | 17K | ||
PIL_glucosamina_HK.pdf | 2019-04-16 16:17 | 23K | ||
PIL_fluconazol_HK.pdf | 2019-04-16 15:50 | 29K | ||
PIL_famotidina_HK-1.pdf | 2019-04-16 15:36 | 46K | ||
PIL_famotidina_HK.pdf | 2019-04-15 16:55 | 46K | ||
PIL_-Diclofenac_HK.pdf | 2019-04-15 16:39 | 47K | ||
PIL_atenolol_HK.pdf | 2019-04-15 15:03 | 161K | ||
PIL_amlodipino_HK.pdf | 2019-04-15 12:52 | 164K | ||
PIL_ambroxol_HK-1.pdf | 2019-04-15 12:39 | 37K | ||
PIL_ambroxol_HK.pdf | 2019-04-15 12:37 | 37K | ||
PL_clopidogrel-cinfa..> | 2019-04-11 16:26 | 62K | ||
SPC_clopidogrel-cinf..> | 2019-04-11 16:25 | 146K | ||
PIL-Co-Irbea_UAE.pdf | 2019-03-28 12:48 | 227K | ||
PIL-Atorcor-atorvast..> | 2019-03-21 10:57 | 236K | ||
PIL_cinfalair-montel..> | 2019-03-11 11:48 | 91K | ||
PIL_Ulcerbrex-rabepr..> | 2019-03-11 11:45 | 89K | ||
PL_enalapril_PA.pdf | 2019-02-13 16:21 | 45K | ||
PL_-enalapril_PA.pdf | 2019-02-13 16:20 | 45K | ||
FT_enalapril_PA.pdf | 2019-02-13 16:20 | 144K | ||
PL_Lisinopril-cinfa_..> | 2019-02-12 17:44 | 51K | ||
SPC_Lisinopril-cinfa..> | 2019-02-12 17:44 | 141K | ||
PL_atorvastatina-3.pdf | 2019-02-12 17:06 | 94K | ||
SPC_atorvastatina-3.pdf | 2019-02-12 17:06 | 332K | ||
PIL_ziquin-levofloxa..> | 2019-02-12 16:01 | 138K | ||
PIL_ziquin-1.pdf | 2019-02-12 16:00 | 138K | ||
PIL_ziquin.pdf | 2019-02-12 15:54 | 138K | ||
revslider/ | 2019-01-22 18:05 | - | ||
js_composer/ | 2019-01-22 18:05 | - | ||
cache/ | 2019-01-22 18:05 | - | ||
AAPL/ | 2019-01-22 18:05 | - | ||
2017/ | 2019-01-22 18:05 | - | ||
2016/ | 2019-01-22 18:05 | - | ||
2015/ | 2019-01-22 18:05 | - | ||
2014/ | 2019-01-22 18:05 | - | ||
2013/ | 2019-01-22 18:05 | - | ||
2012/ | 2019-01-22 18:04 | - | ||
flags/ | 2019-01-22 18:01 | - | ||
PIL_cinfalair-chewab..> | 2019-01-14 16:57 | 168K | ||
desciption-drugs-cin..> | 2018-12-21 13:05 | 77K | ||
desciption-drugs-cin..> | 2018-12-21 13:05 | 23K | ||
desciption-drugs-cin..> | 2018-12-21 13:05 | 30K | ||
desciption-drugs-cin..> | 2018-12-21 13:05 | 24K | ||
desciption-drugs-cin..> | 2018-12-21 13:05 | 15K | ||
desciption-drugs-cin..> | 2018-12-21 13:05 | 13K | ||
desciption-drugs-cin..> | 2018-12-21 13:05 | 14K | ||
desciption-drugs-cin..> | 2018-12-21 13:05 | 13K | ||
desciption-drugs-cin..> | 2018-12-21 13:05 | 14K | ||
desciption-drugs-cin..> | 2018-12-21 13:05 | 11K | ||
desciption-drugs-cin..> | 2018-12-21 13:05 | 7.0K | ||
desciption-drugs-cin..> | 2018-12-21 13:05 | 6.0K | ||
desciption-drugs-cin..> | 2018-12-21 13:05 | 4.3K | ||
desciption-drugs-cin..> | 2018-12-21 13:05 | 2.0K | ||
PIL_Loratadina-Compr..> | 2018-12-18 10:28 | 27K | ||
SPC_Loratadina-Compr..> | 2018-12-18 10:28 | 107K | ||
PIL_Cinfalair-Film-C..> | 2018-12-17 16:49 | 116K | ||
PIL_Cinfalair-Paedia..> | 2018-12-17 16:48 | 92K | ||
PIL_Cinfalair-montel..> | 2018-12-17 16:48 | 168K | ||
PL_atorvastatina-2.pdf | 2018-12-14 13:37 | 92K | ||
SPC_atorvastatina-2.pdf | 2018-12-14 13:37 | 336K | ||
PIL_lansoprazol.pdf | 2018-12-13 10:20 | 110K | ||
SPC_lansoprazol.pdf | 2018-12-13 10:20 | 125K | ||
PIL-Irbea-Irbesartan..> | 2018-12-13 10:11 | 201K | ||
PIL-Co-Irbea.pdf | 2018-12-13 10:05 | 220K | ||
cinfa-1.png | 2018-12-11 09:42 | 2.6K | ||
cinfa-1-150x55.png | 2018-12-11 09:42 | 1.8K | ||
PIL-ziquin-levofloxa..> | 2018-11-21 17:49 | 137K | ||
es-pl-ciprofloxacino..> | 2018-10-26 14:00 | 108K | ||
es-spc-ciprofloxacin..> | 2018-10-26 14:00 | 167K | ||
header-Mobility-Farm..> | 2018-10-23 17:55 | 76K | ||
header-Mobility-Farm..> | 2018-10-23 17:55 | 20K | ||
header-Mobility-Farm..> | 2018-10-23 17:55 | 38K | ||
header-Mobility-Farm..> | 2018-10-23 17:55 | 31K | ||
header-Mobility-Farm..> | 2018-10-23 17:55 | 12K | ||
header-Mobility-Farm..> | 2018-10-23 17:55 | 11K | ||
header-Mobility-Farm..> | 2018-10-23 17:55 | 21K | ||
header-Mobility-Farm..> | 2018-10-23 17:55 | 20K | ||
header-Mobility-Farm..> | 2018-10-23 17:55 | 19K | ||
header-Mobility-Farm..> | 2018-10-23 17:55 | 17K | ||
header-Mobility-Farm..> | 2018-10-23 17:55 | 11K | ||
header-Mobility-Farm..> | 2018-10-23 17:55 | 8.4K | ||
header-Mobility-Farm..> | 2018-10-23 17:55 | 3.2K | ||
header-Mobility-Farm..> | 2018-10-23 17:55 | 3.0K | ||
Farmalastic-intdef-7..> | 2018-10-23 17:55 | 27K | ||
Farmalastic-intdef-5..> | 2018-10-23 17:55 | 18K | ||
Farmalastic-intdef-5..> | 2018-10-23 17:55 | 26K | ||
Farmalastic-intdef-5..> | 2018-10-23 17:55 | 20K | ||
Farmalastic-intdef-4..> | 2018-10-23 17:55 | 12K | ||
Farmalastic-intdef-3..> | 2018-10-23 17:55 | 9.6K | ||
Farmalastic-intdef.jpg | 2018-10-23 17:55 | 38K | ||
Farmalastic-intdef-6..> | 2018-10-23 17:55 | 30K | ||
Farmalastic-intdef-5..> | 2018-10-23 17:55 | 29K | ||
Farmalastic-intdef-3..> | 2018-10-23 17:55 | 8.0K | ||
Farmalastic-intdef-1..> | 2018-10-23 17:55 | 4.3K | ||
PIL_garidol_PAN.pdf | 2018-09-25 12:05 | 25K | ||
SPC_garidol_PAN.pdf | 2018-09-25 12:04 | 26K | ||
CINFA-PIPELINE-Octob..> | 2018-09-25 08:57 | 175K | ||
PIL_Xflox-moxifloxac..> | 2018-09-24 13:40 | 74K | ||
PIL_cinfalair-montel..> | 2018-09-21 10:55 | 40K | ||
PIL_cinfalair-montel..> | 2018-09-21 10:54 | 53K | ||
PIL_cinfalair-montel..> | 2018-09-21 10:53 | 58K | ||
PIL_ziquin-levofloxa..> | 2018-09-21 10:44 | 137K | ||
PIL_ziquin-levofloxa..> | 2018-09-21 10:42 | 137K | ||
PIL_atorcor_QA.pdf | 2018-09-21 10:36 | 186K | ||
PIL-Ulcerbrex-rabepr..> | 2018-09-21 10:30 | 91K | ||
PIL_ulcerbrex-rabepr..> | 2018-09-21 10:24 | 95K | ||
PL_gablix-pregabalin..> | 2018-09-21 10:10 | 248K | ||
PIPELINE-October-201..> | 2018-09-19 08:53 | 175K | ||
PIL_Lebalin_KSA-1.pdf | 2018-09-14 11:10 | 170K | ||
PIL_Lebalin_KSA.pdf | 2018-09-14 11:08 | 166K | ||
PIL_-Flomocin_KSA.pdf | 2018-09-14 11:06 | 105K | ||
PIL_irbesartan-compr..> | 2018-08-22 13:06 | 38K | ||
SPC_irbesartan-compr..> | 2018-08-22 13:05 | 123K | ||
header-genericos-1.jpg | 2018-07-30 11:13 | 83K | ||
header-genericos-1-1..> | 2018-07-30 11:13 | 27K | ||
header-genericos-1-1..> | 2018-07-30 11:13 | 39K | ||
header-genericos-1-8..> | 2018-07-30 11:13 | 32K | ||
header-genericos-1-7..> | 2018-07-30 11:13 | 18K | ||
header-genericos-1-7..> | 2018-07-30 11:13 | 15K | ||
header-genericos-1-6..> | 2018-07-30 11:13 | 20K | ||
header-genericos-1-5..> | 2018-07-30 11:13 | 19K | ||
header-genericos-1-5..> | 2018-07-30 11:13 | 18K | ||
header-genericos-1-5..> | 2018-07-30 11:13 | 16K | ||
header-genericos-1-4..> | 2018-07-30 11:13 | 11K | ||
header-genericos-1-3..> | 2018-07-30 11:13 | 8.5K | ||
header-genericos-1-3..> | 2018-07-30 11:13 | 4.6K | ||
header-genericos-1-1..> | 2018-07-30 11:13 | 3.0K | ||
genericos-noname.jpg | 2018-07-30 11:13 | 53K | ||
genericos-noname-600..> | 2018-07-30 11:13 | 43K | ||
genericos-noname-570..> | 2018-07-30 11:13 | 41K | ||
genericos-noname-539..> | 2018-07-30 11:13 | 29K | ||
genericos-noname-500..> | 2018-07-30 11:13 | 37K | ||
genericos-noname-500..> | 2018-07-30 11:13 | 32K | ||
genericos-noname-400..> | 2018-07-30 11:13 | 22K | ||
genericos-noname-345..> | 2018-07-30 11:13 | 16K | ||
genericos-noname-300..> | 2018-07-30 11:13 | 15K | ||
genericos-noname-150..> | 2018-07-30 11:13 | 7.7K | ||
PIL-Xflox-moxifloxac..> | 2018-07-20 10:42 | 73K | ||
Value-Transfers-Meth..> | 2018-06-29 12:04 | 1.1M | ||
Transfers-of-value-C..> | 2018-06-29 12:04 | 2.0M | ||
1-1024x453.jpg | 2018-06-20 13:18 | 84K | ||
1-1000x500.jpg | 2018-06-20 13:18 | 90K | ||
2-1-1000x850.jpg | 2018-06-20 13:18 | 78K | ||
2-1-1000x500.jpg | 2018-06-20 13:18 | 57K | ||
1.jpg | 2018-06-20 13:18 | 138K | ||
1-1000x850.jpg | 2018-06-20 13:18 | 134K | ||
1-800x600.jpg | 2018-06-20 13:18 | 85K | ||
1-768x340.jpg | 2018-06-20 13:18 | 53K | ||
1-700x310.jpg | 2018-06-20 13:18 | 46K | ||
1-630x300.jpg | 2018-06-20 13:18 | 41K | ||
1-600x800.jpg | 2018-06-20 13:18 | 79K | ||
1-570x570.jpg | 2018-06-20 13:18 | 62K | ||
1-539x303.jpg | 2018-06-20 13:18 | 37K | ||
1-500x850.jpg | 2018-06-20 13:18 | 71K | ||
1-500x500.jpg | 2018-06-20 13:18 | 51K | ||
1-500x380.jpg | 2018-06-20 13:18 | 42K | ||
1-400x260.jpg | 2018-06-20 13:18 | 26K | ||
1-345x198.jpg | 2018-06-20 13:18 | 18K | ||
1-300x240.jpg | 2018-06-20 13:18 | 19K | ||
1-300x133.jpg | 2018-06-20 13:18 | 12K | ||
1-150x150.jpg | 2018-06-20 13:18 | 7.8K | ||
1-100x50.jpg | 2018-06-20 13:18 | 3.0K | ||
CINFA-company_profil..> | 2018-06-20 13:18 | 3.3M | ||
Be-int.-570x483.jpg | 2018-06-20 13:18 | 33K | ||
ACCESSIBLE-HEALTH-34..> | 2018-06-20 13:18 | 21K | ||
ACCESSIBLE-HEALTH-30..> | 2018-06-20 13:18 | 28K | ||
ACCESSIBLE-HEALTH-15..> | 2018-06-20 13:18 | 9.8K | ||
3p.jpg | 2018-06-20 13:18 | 31K | ||
3p-600x363.jpg | 2018-06-20 13:18 | 30K | ||
3p-570x363.jpg | 2018-06-20 13:18 | 29K | ||
3p-539x303.jpg | 2018-06-20 13:18 | 23K | ||
3p-500x363.jpg | 2018-06-20 13:18 | 28K | ||
3p-400x260.jpg | 2018-06-20 13:18 | 17K | ||
3p-345x198.jpg | 2018-06-20 13:18 | 13K | ||
3p-300x182.jpg | 2018-06-20 13:18 | 11K | ||
3p-150x150.jpg | 2018-06-20 13:18 | 6.8K | ||
3-1.jpg | 2018-06-20 13:18 | 186K | ||
3-1-1024x453.jpg | 2018-06-20 13:18 | 44K | ||
3-1-1000x850.jpg | 2018-06-20 13:18 | 96K | ||
3-1-1000x500.jpg | 2018-06-20 13:18 | 50K | ||
3-1-800x600.jpg | 2018-06-20 13:18 | 51K | ||
3-1-768x340.jpg | 2018-06-20 13:18 | 26K | ||
3-1-700x310.jpg | 2018-06-20 13:18 | 22K | ||
3-1-630x300.jpg | 2018-06-20 13:18 | 20K | ||
3-1-600x800.jpg | 2018-06-20 13:18 | 49K | ||
3-1-570x570.jpg | 2018-06-20 13:18 | 36K | ||
3-1-539x303.jpg | 2018-06-20 13:18 | 19K | ||
3-1-500x850.jpg | 2018-06-20 13:18 | 48K | ||
3-1-500x500.jpg | 2018-06-20 13:18 | 29K | ||
3-1-500x380.jpg | 2018-06-20 13:18 | 23K | ||
3-1-400x260.jpg | 2018-06-20 13:18 | 13K | ||
3-1-345x198.jpg | 2018-06-20 13:18 | 9.6K | ||
3-1-300x240.jpg | 2018-06-20 13:18 | 9.9K | ||
3-1-300x133.jpg | 2018-06-20 13:18 | 6.0K | ||
3-1-150x150.jpg | 2018-06-20 13:18 | 4.5K | ||
3-1-100x50.jpg | 2018-06-20 13:18 | 2.6K | ||
2-1.jpg | 2018-06-20 13:18 | 194K | ||
2-1-1024x453.jpg | 2018-06-20 13:18 | 55K | ||
2-1-800x600.jpg | 2018-06-20 13:18 | 50K | ||
2-1-768x340.jpg | 2018-06-20 13:18 | 35K | ||
2-1-700x310.jpg | 2018-06-20 13:18 | 30K | ||
2-1-630x300.jpg | 2018-06-20 13:18 | 27K | ||
2-1-600x800.jpg | 2018-06-20 13:18 | 50K | ||
2-1-570x570.jpg | 2018-06-20 13:18 | 37K | ||
2-1-539x303.jpg | 2018-06-20 13:18 | 23K | ||
2-1-500x850.jpg | 2018-06-20 13:18 | 48K | ||
2-1-500x500.jpg | 2018-06-20 13:18 | 30K | ||
2-1-500x380.jpg | 2018-06-20 13:18 | 26K | ||
2-1-400x260.jpg | 2018-06-20 13:18 | 17K | ||
2-1-345x198.jpg | 2018-06-20 13:18 | 12K | ||
2-1-300x240.jpg | 2018-06-20 13:18 | 13K | ||
2-1-300x133.jpg | 2018-06-20 13:18 | 8.6K | ||
2-1-150x150.jpg | 2018-06-20 13:18 | 5.8K | ||
Cinfa-Worldwide-1024..> | 2018-06-20 13:18 | 16K | ||
Cinfa-Worldwide-1000..> | 2018-06-20 13:18 | 31K | ||
Cinfa-Worldwide-570x..> | 2018-06-20 13:18 | 16K | ||
Cinfa-Group.jpg | 2018-06-20 13:18 | 51K | ||
Cinfa-Group-1.jpg | 2018-06-20 13:18 | 51K | ||
Cinfa-Group-1-1024x1..> | 2018-06-20 13:18 | 17K | ||
Cinfa-Group-1-1000x3..> | 2018-06-20 13:18 | 33K | ||
Cinfa-Group-1-800x30..> | 2018-06-20 13:18 | 27K | ||
Cinfa-Group-1-768x12..> | 2018-06-20 13:18 | 11K | ||
Cinfa-Group-1-700x11..> | 2018-06-20 13:18 | 9.7K | ||
Cinfa-Group-1-600x30..> | 2018-06-20 13:18 | 20K | ||
Cinfa-Group-1-570x30..> | 2018-06-20 13:18 | 19K | ||
Cinfa-Group-1-539x30..> | 2018-06-20 13:18 | 18K | ||
Cinfa-Group-1-500x30..> | 2018-06-20 13:18 | 16K | ||
Cinfa-Group-1-400x26..> | 2018-06-20 13:18 | 10K | ||
Cinfa-Group-1-345x19..> | 2018-06-20 13:18 | 8.0K | ||
Cinfa-Group-1-300x47..> | 2018-06-20 13:18 | 3.5K | ||
Cinfa-Group-1-150x15..> | 2018-06-20 13:18 | 3.6K | ||
Captopril-es-spc.pdf | 2018-06-20 13:18 | 105K | ||
Captopril-es-pl.pdf | 2018-06-20 13:18 | 41K | ||
Biotech.jpg | 2018-06-20 13:18 | 32K | ||
Biotech-600x363.jpg | 2018-06-20 13:18 | 31K | ||
Biotech-570x363.jpg | 2018-06-20 13:18 | 30K | ||
Biotech-539x303.jpg | 2018-06-20 13:18 | 25K | ||
Biotech-500x363.jpg | 2018-06-20 13:18 | 28K | ||
Biotech-400x260.jpg | 2018-06-20 13:18 | 19K | ||
Biotech-345x198.jpg | 2018-06-20 13:18 | 14K | ||
Biotech-300x182.jpg | 2018-06-20 13:18 | 12K | ||
Biotech-150x150.jpg | 2018-06-20 13:18 | 6.3K | ||
Be-int..jpg | 2018-06-20 13:18 | 34K | ||
Be-int.-700x466.jpg | 2018-06-20 13:18 | 30K | ||
Be-int.-600x483.jpg | 2018-06-20 13:18 | 33K | ||
Be-int.-539x303.jpg | 2018-06-20 13:18 | 19K | ||
Be-int.-500x483.jpg | 2018-06-20 13:18 | 30K | ||
Be-int.-500x380.jpg | 2018-06-20 13:18 | 21K | ||
Be-int.-400x260.jpg | 2018-06-20 13:18 | 12K | ||
Be-int.-345x198.jpg | 2018-06-20 13:18 | 9.8K | ||
Be-int.-300x200.jpg | 2018-06-20 13:18 | 8.1K | ||
Be-int.-150x150.jpg | 2018-06-20 13:18 | 4.8K | ||
ACCESSIBLE-HEALTH.jpg | 2018-06-20 13:18 | 64K | ||
ACCESSIBLE-HEALTH-50..> | 2018-06-20 13:18 | 64K | ||
ACCESSIBLE-HEALTH-50..> | 2018-06-20 13:18 | 50K | ||
ACCESSIBLE-HEALTH-50..> | 2018-06-20 13:18 | 40K | ||
ACCESSIBLE-HEALTH-40..> | 2018-06-20 13:18 | 29K | ||
Genericos-int.-def-5..> | 2018-06-20 13:18 | 25K | ||
For-and-with-the-pat..> | 2018-06-20 13:18 | 214K | ||
For-and-with-the-pat..> | 2018-06-20 13:18 | 74K | ||
For-and-with-the-pat..> | 2018-06-20 13:18 | 105K | ||
For-and-with-the-pat..> | 2018-06-20 13:18 | 86K | ||
For-and-with-the-pat..> | 2018-06-20 13:18 | 37K | ||
For-and-with-the-pat..> | 2018-06-20 13:18 | 67K | ||
For-and-with-the-pat..> | 2018-06-20 13:18 | 64K | ||
For-and-with-the-pat..> | 2018-06-20 13:18 | 62K | ||
For-and-with-the-pat..> | 2018-06-20 13:18 | 58K | ||
For-and-with-the-pat..> | 2018-06-20 13:18 | 40K | ||
For-and-with-the-pat..> | 2018-06-20 13:18 | 29K | ||
For-and-with-the-pat..> | 2018-06-20 13:18 | 7.9K | ||
For-and-with-the-pat..> | 2018-06-20 13:18 | 11K | ||
Farmalastic-int.-def..> | 2018-06-20 13:18 | 47K | ||
Farmalastic-int.-def..> | 2018-06-20 13:18 | 41K | ||
Farmalastic-int.-def..> | 2018-06-20 13:18 | 47K | ||
Farmalastic-int.-def..> | 2018-06-20 13:18 | 47K | ||
Farmalastic-int.-def..> | 2018-06-20 13:18 | 27K | ||
Farmalastic-int.-def..> | 2018-06-20 13:18 | 44K | ||
Farmalastic-int.-def..> | 2018-06-20 13:18 | 30K | ||
Farmalastic-int.-def..> | 2018-06-20 13:18 | 17K | ||
Farmalastic-int.-def..> | 2018-06-20 13:18 | 14K | ||
Farmalastic-int.-def..> | 2018-06-20 13:18 | 11K | ||
Farmalastic-int.-def..> | 2018-06-20 13:18 | 6.9K | ||
Cyndea.jpg | 2018-06-20 13:18 | 37K | ||
Cyndea-600x363.jpg | 2018-06-20 13:18 | 36K | ||
Cyndea-570x363.jpg | 2018-06-20 13:18 | 34K | ||
Cyndea-539x303.jpg | 2018-06-20 13:18 | 27K | ||
Cyndea-500x363.jpg | 2018-06-20 13:18 | 31K | ||
Cyndea-400x260.jpg | 2018-06-20 13:18 | 19K | ||
Cyndea-345x198.jpg | 2018-06-20 13:18 | 14K | ||
Cyndea-300x182.jpg | 2018-06-20 13:18 | 12K | ||
Cyndea-150x150.jpg | 2018-06-20 13:18 | 6.8K | ||
Cinfa_OTC_product_pi..> | 2018-06-20 13:18 | 151K | ||
Cinfa_Generics_produ..> | 2018-06-20 13:18 | 175K | ||
Cinfa-Worldwide.jpg | 2018-06-20 13:18 | 37K | ||
Cinfa-Worldwide-800x..> | 2018-06-20 13:18 | 24K | ||
Cinfa-Worldwide-768x..> | 2018-06-20 13:18 | 11K | ||
Cinfa-Worldwide-700x..> | 2018-06-20 13:18 | 9.2K | ||
Cinfa-Worldwide-600x..> | 2018-06-20 13:18 | 17K | ||
Cinfa-Worldwide-539x..> | 2018-06-20 13:18 | 16K | ||
Cinfa-Worldwide-500x..> | 2018-06-20 13:18 | 16K | ||
Cinfa-Worldwide-400x..> | 2018-06-20 13:18 | 12K | ||
Cinfa-Worldwide-345x..> | 2018-06-20 13:18 | 9.1K | ||
Cinfa-Worldwide-300x..> | 2018-06-20 13:18 | 3.4K | ||
Cinfa-Worldwide-150x..> | 2018-06-20 13:18 | 5.2K | ||
Manufacture-and-faci..> | 2018-06-20 13:18 | 45K | ||
Manufacture-and-faci..> | 2018-06-20 13:18 | 72K | ||
Leading-Laboratory.jpg | 2018-06-20 13:18 | 74K | ||
Leading-Laboratory-1..> | 2018-06-20 13:18 | 27K | ||
Leading-Laboratory-1..> | 2018-06-20 13:18 | 28K | ||
Leading-Laboratory-6..> | 2018-06-20 13:18 | 12K | ||
Leading-Laboratory-5..> | 2018-06-20 13:18 | 11K | ||
Leading-Laboratory-5..> | 2018-06-20 13:18 | 10K | ||
Leading-Laboratory-4..> | 2018-06-20 13:18 | 7.1K | ||
Leading-Laboratory-3..> | 2018-06-20 13:18 | 5.8K | ||
Leading-Laboratory-3..> | 2018-06-20 13:18 | 5.0K | ||
Leading-Laboratory-1..> | 2018-06-20 13:18 | 2.8K | ||
HH_PR_034_001.pdf | 2018-06-20 13:18 | 204K | ||
HH_FT_034_001.pdf | 2018-06-20 13:18 | 597K | ||
HH_FT_034_001-1.pdf | 2018-06-20 13:18 | 597K | ||
Genericos-int.-def.jpg | 2018-06-20 13:18 | 43K | ||
Genericos-int.-def-7..> | 2018-06-20 13:18 | 37K | ||
Genericos-int.-def-6..> | 2018-06-20 13:18 | 42K | ||
Genericos-int.-def-5..> | 2018-06-20 13:18 | 41K | ||
Genericos-int.-def-5..> | 2018-06-20 13:18 | 38K | ||
Genericos-int.-def-5..> | 2018-06-20 13:18 | 26K | ||
Genericos-int.-def-4..> | 2018-06-20 13:18 | 15K | ||
Genericos-int.-def-3..> | 2018-06-20 13:18 | 12K | ||
Genericos-int.-def-3..> | 2018-06-20 13:18 | 9.9K | ||
Genericos-int.-def-1..> | 2018-06-20 13:18 | 5.7K | ||
For-and-with-the-pat..> | 2018-06-20 13:18 | 44K | ||
Orliman-150x150.jpg | 2018-06-20 13:18 | 0 | ||
ORLIMAN-2-150x150.jpg | 2018-06-20 13:18 | 7.5K | ||
ORLIMAN-1.jpg | 2018-06-20 13:18 | 35K | ||
ORLIMAN-1-600x363.jpg | 2018-06-20 13:18 | 35K | ||
ORLIMAN-1-570x363.jpg | 2018-06-20 13:18 | 34K | ||
ORLIMAN-1-539x303.jpg | 2018-06-20 13:18 | 26K | ||
ORLIMAN-1-500x363.jpg | 2018-06-20 13:18 | 32K | ||
ORLIMAN-1-400x260.jpg | 2018-06-20 13:18 | 19K | ||
ORLIMAN-1-345x198.jpg | 2018-06-20 13:18 | 14K | ||
ORLIMAN-1-300x182.jpg | 2018-06-20 13:18 | 12K | ||
ORLIMAN-1-150x150.jpg | 2018-06-20 13:18 | 7.5K | ||
Ns-int..jpg | 2018-06-20 13:18 | 40K | ||
Ns-int.-700x466.jpg | 2018-06-20 13:18 | 35K | ||
Ns-int.-600x483.jpg | 2018-06-20 13:18 | 40K | ||
Ns-int.-570x483.jpg | 2018-06-20 13:18 | 40K | ||
Ns-int.-539x303.jpg | 2018-06-20 13:18 | 23K | ||
Ns-int.-500x483.jpg | 2018-06-20 13:18 | 38K | ||
Ns-int.-500x380.jpg | 2018-06-20 13:18 | 25K | ||
Ns-int.-400x260.jpg | 2018-06-20 13:18 | 15K | ||
Ns-int.-345x198.jpg | 2018-06-20 13:18 | 11K | ||
Ns-int.-300x200.jpg | 2018-06-20 13:18 | 9.4K | ||
Ns-int.-150x150.jpg | 2018-06-20 13:18 | 5.5K | ||
Manufacture-and-faci..> | 2018-06-20 13:18 | 140K | ||
Manufacture-and-faci..> | 2018-06-20 13:18 | 55K | ||
Manufacture-and-faci..> | 2018-06-20 13:18 | 28K | ||
Manufacture-and-faci..> | 2018-06-20 13:18 | 24K | ||
Manufacture-and-faci..> | 2018-06-20 13:18 | 43K | ||
Manufacture-and-faci..> | 2018-06-20 13:18 | 41K | ||
Manufacture-and-faci..> | 2018-06-20 13:18 | 40K | ||
Manufacture-and-faci..> | 2018-06-20 13:18 | 38K | ||
Manufacture-and-faci..> | 2018-06-20 13:18 | 25K | ||
Manufacture-and-faci..> | 2018-06-20 13:18 | 18K | ||
Manufacture-and-faci..> | 2018-06-20 13:18 | 7.1K | ||
Manufacture-and-faci..> | 2018-06-20 13:18 | 7.9K | ||
Leading-Laboratory-8..> | 2018-06-20 13:18 | 20K | ||
Leading-Laboratory-7..> | 2018-06-20 13:18 | 17K | ||
Leading-Laboratory-7..> | 2018-06-20 13:18 | 15K | ||
Leading-Laboratory-5..> | 2018-06-20 13:18 | 11K | ||
sakura.jpg | 2018-06-20 13:18 | 48K | ||
sakura-570x363.jpg | 2018-06-20 13:18 | 12K | ||
sakura-300x182.jpg | 2018-06-20 13:18 | 15K | ||
sakura-150x150.jpg | 2018-06-20 13:18 | 7.4K | ||
PL_ziquin-levofloxac..> | 2018-06-20 13:18 | 84K | ||
Orliman.jpg | 2018-06-20 13:18 | 35K | ||
ORLIMAN-2.jpg | 2018-06-20 13:18 | 35K | ||
ORLIMAN-2-600x363.jpg | 2018-06-20 13:18 | 35K | ||
ORLIMAN-2-570x363.jpg | 2018-06-20 13:18 | 34K | ||
ORLIMAN-2-539x303.jpg | 2018-06-20 13:18 | 26K | ||
ORLIMAN-2-500x363.jpg | 2018-06-20 13:18 | 32K | ||
ORLIMAN-2-400x260.jpg | 2018-06-20 13:18 | 19K | ||
ORLIMAN-2-345x198.jpg | 2018-06-20 13:18 | 14K | ||
ORLIMAN-2-300x182.jpg | 2018-06-20 13:18 | 12K | ||
Orliman-570x363.jpg | 2018-06-20 13:13 | 83K | ||
Orliman-539x303.jpg | 2018-06-20 13:13 | 59K | ||
Orliman-500x363.jpg | 2018-06-20 13:13 | 73K | ||
Orliman-400x260.jpg | 2018-06-20 13:13 | 39K | ||
Orliman-345x198.jpg | 2018-06-20 13:13 | 27K | ||
Orliman-300x182.jpg | 2018-06-20 13:13 | 21K | ||
PATIENTS-ASSOCIATION..> | 2018-06-20 13:13 | 46K | ||
PATIENTS-ASSOCIATION..> | 2018-06-20 13:13 | 37K | ||
PATIENTS-ASSOCIATION..> | 2018-06-20 13:13 | 25K | ||
PATIENTS-ASSOCIATION..> | 2018-06-20 13:13 | 18K | ||
PATIENTS-ASSOCIATION..> | 2018-06-20 13:13 | 24K | ||
PATIENTS-ASSOCIATION..> | 2018-06-20 13:13 | 8.3K | ||
Orliman-600x363.jpg | 2018-06-20 13:13 | 88K | ||
PIL-Irbea_KW.pdf | 2018-06-20 13:13 | 198K | ||
PIL-Irbea-Irbesartan..> | 2018-06-20 13:13 | 201K | ||
PATIENTS-ASSOCIATION..> | 2018-06-20 13:13 | 61K | ||
PATIENTS-ASSOCIATION..> | 2018-06-20 13:13 | 61K | ||
PIL-co-cinfaval-vals..> | 2018-06-20 13:13 | 240K | ||
PIL-Xflox-moxifloxac..> | 2018-06-20 13:13 | 90K | ||
PIL-Xflox-moxifloxac..> | 2018-06-20 13:13 | 89K | ||
PIL-Xflox-moxifloxac..> | 2018-06-20 13:13 | 89K | ||
PIL-ziquin-levofloxa..> | 2018-06-20 13:13 | 141K | ||
PIL-ulcerbrex-rabepr..> | 2018-06-20 13:13 | 90K | ||
PIL-co-cinfaval-vals..> | 2018-06-20 13:13 | 238K | ||
PIL_Co-Irbea_KW.pdf | 2018-06-20 13:13 | 220K | ||
PIL_Cinfaval-Valsart..> | 2018-06-20 13:13 | 90K | ||
PIL-ziquin-levofloxa..> | 2018-06-20 13:13 | 137K | ||
PIL-ziquin-levofloxa..> | 2018-06-20 13:13 | 141K | ||
PIL_Coxicel-Celecoxi..> | 2018-06-20 13:13 | 94K | ||
PIL_Coxicel-Celecoxi..> | 2018-06-20 13:13 | 94K | ||
PIL_ulcerbrex-rabepr..> | 2018-06-20 13:13 | 94K | ||
PIL_Ulcerbrex-rabepr..> | 2018-06-20 13:13 | 90K | ||
PIL_Ulcerbrex-rabepr..> | 2018-06-20 13:13 | 89K | ||
PL-atorcor-atorvasta..> | 2018-06-20 13:13 | 177K | ||
PL-atorcor-atorvasta..> | 2018-06-20 13:13 | 181K | ||
PL-_diclofenaco_50mg..> | 2018-06-20 13:13 | 40K | ||
PL-_diclofenaco_50mg..> | 2018-06-20 13:13 | 44K | ||
PL-diclofenaco-50mg-..> | 2018-06-20 13:13 | 88K | ||
PL-cinfaval-valsarta..> | 2018-06-20 13:13 | 140K | ||
PL-cinfaval-valsarta..> | 2018-06-20 13:13 | 144K | ||
PL_Co-Irbea-1.pdf | 2018-06-20 13:13 | 139K | ||
PL-diclofenaco-50mg.pdf | 2018-06-20 13:13 | 80K | ||
PL_Ibufen_400mg-1.pdf | 2018-06-20 13:13 | 74K | ||
PL_Histabentine-beta..> | 2018-06-20 13:13 | 148K | ||
PL_Co-Irbea.pdf | 2018-06-20 13:13 | 135K | ||
PL_Lisinopril-cinfa_..> | 2018-06-20 13:13 | 38K | ||
PL_Ibufen_400mg.pdf | 2018-06-20 13:13 | 74K | ||
PL_atorvastatina-1.pdf | 2018-06-20 13:13 | 74K | ||
PL_amlodipino-cinfa_..> | 2018-06-20 13:13 | 81K | ||
PL_amlodipino-cinfa_..> | 2018-06-20 13:13 | 85K | ||
PL_ambroxol-jarabe_1..> | 2018-06-20 13:13 | 16K | ||
PL_ambroxol-jarabe_1..> | 2018-06-20 13:13 | 20K | ||
PL_ambroxol-jarabe_1..> | 2018-06-20 13:13 | 16K | ||
PL_Ziquin-levofloxac..> | 2018-06-20 13:13 | 100K | ||
PL_Ziquin-levofloxac..> | 2018-06-20 13:13 | 88K | ||
PL_Lisinopril-cinfa_..> | 2018-06-20 13:13 | 34K | ||
PL_azitromicina_500-..> | 2018-06-20 13:13 | 36K | ||
PL_atorvastatina.pdf | 2018-06-20 13:13 | 70K | ||
PL_atenolol-cinfa_10..> | 2018-06-20 13:13 | 81K | ||
PL_atenolol-cinfa_10..> | 2018-06-20 13:13 | 85K | ||
PL_atenolol-cinfa_10..> | 2018-06-20 13:13 | 81K | ||
PL_amoxicilina_500-m..> | 2018-06-20 13:13 | 20K | ||
PL_amoxicilina_500-m..> | 2018-06-20 13:13 | 24K | ||
PL_cinfalair-montelu..> | 2018-06-20 13:13 | 45K | ||
PL_cinfalair-montelu..> | 2018-06-20 13:13 | 49K | ||
PL_cinfalair-montelu..> | 2018-06-20 13:13 | 61K | ||
PL_cinfalair-montelu..> | 2018-06-20 13:13 | 54K | ||
PL_cinfalair-montelu..> | 2018-06-20 13:13 | 65K | ||
PL_cinfalair-montelu..> | 2018-06-20 13:13 | 50K | ||
PL_cinfalair-montelu..> | 2018-06-20 13:13 | 61K | ||
PL_cetirizina_10mg.pdf | 2018-06-20 13:13 | 18K | ||
PL_cetirizina_10mg-1..> | 2018-06-20 13:13 | 22K | ||
PL_cetiricina-cyndea..> | 2018-06-20 13:13 | 18K | ||
PL_cetiricina-cyndea..> | 2018-06-20 13:13 | 22K | ||
PL_captopril_25mg.pdf | 2018-06-20 13:13 | 38K | ||
PL_captopril_25mg-1.pdf | 2018-06-20 13:13 | 46K | ||
PL_captopril-comprim..> | 2018-06-20 13:13 | 41K | ||
PL_captopril-comprim..> | 2018-06-20 13:13 | 49K | ||
PL_azitromicina_500-..> | 2018-06-20 13:13 | 32K | ||
PL_ciprofloxacino_50..> | 2018-06-20 13:13 | 47K | ||
PL_cinfaval-valsarta..> | 2018-06-20 13:13 | 117K | ||
PL_cinfaval-valsarta..> | 2018-06-20 13:13 | 121K | ||
PL_cinfatos-expector..> | 2018-06-20 13:13 | 35K | ||
PL_cinfatos-expector..> | 2018-06-20 13:13 | 39K | ||
PL_cinfalair-montelu..> | 2018-06-20 13:13 | 32K | ||
PL_cinfalair-montelu..> | 2018-06-20 13:13 | 32K | ||
PL_cinfalair-montelu..> | 2018-06-20 13:13 | 36K | ||
PL_cinfalair-montelu..> | 2018-06-20 13:13 | 36K | ||
PL_cinfalair-montelu..> | 2018-06-20 13:13 | 45K | ||
PL_cinfalair-montelu..> | 2018-06-20 13:13 | 49K | ||
PL_co-cinfaval-valsa..> | 2018-06-20 13:13 | 95K | ||
PL_co-cinfaval-valsa..> | 2018-06-20 13:13 | 98K | ||
PL_co-cinfaval-valsa..> | 2018-06-20 13:13 | 99K | ||
PL_co-cinfaval-valsa..> | 2018-06-20 13:13 | 94K | ||
PL_clopidogrel-cinfa..> | 2018-06-20 13:13 | 58K | ||
PL_clopidogrel-cinfa..> | 2018-06-20 13:13 | 62K | ||
PL_ciprofloxacino_50..> | 2018-06-20 13:13 | 43K | ||
PL_fluoxetina-compri..> | 2018-06-20 13:13 | 31K | ||
PL_fluoxetina-compri..> | 2018-06-20 13:13 | 35K | ||
PL_fluconazol-cinfa-..> | 2018-06-20 13:13 | 49K | ||
PL_fluconazol-cinfa-..> | 2018-06-20 13:13 | 53K | ||
PL_enalapril-enalapr..> | 2018-06-20 13:13 | 29K | ||
PL_enalapril-enalapr..> | 2018-06-20 13:13 | 33K | ||
PL_diclofenaco-cynde..> | 2018-06-20 13:13 | 37K | ||
PL_diclofenaco-cynde..> | 2018-06-20 13:13 | 41K | ||
PL_coxicel-celecoxib..> | 2018-06-20 13:13 | 90K | ||
PL_coxicel-celecoxib..> | 2018-06-20 13:13 | 94K | ||
PL_gablix-pregabalin..> | 2018-06-20 13:13 | 244K | ||
PL_gablix-pregabalin..> | 2018-06-20 13:13 | 248K | ||
PL_furosemida-compr_..> | 2018-06-20 13:13 | 99K | ||
PL_furosemida-compr_..> | 2018-06-20 13:13 | 103K | ||
PL_irbesartan-compr_..> | 2018-06-20 13:13 | 38K | ||
PL_irbesartan-compr_..> | 2018-06-20 13:13 | 37K | ||
PL_irbesartan-compr_..> | 2018-06-20 13:13 | 41K | ||
PL_irbea-irbesartan.pdf | 2018-06-20 13:13 | 149K | ||
PL_irbea-irbesartan-..> | 2018-06-20 13:13 | 153K | ||
PL_garydol.pdf | 2018-06-20 13:13 | 13K | ||
PL_garydol-1.pdf | 2018-06-20 13:13 | 17K | ||
PL_meloxicammeloxica..> | 2018-06-20 13:13 | 46K | ||
PL_losartan-compr.pdf | 2018-06-20 13:13 | 87K | ||
PL_losartan-compr-1.pdf | 2018-06-20 13:13 | 91K | ||
PL_loratadina-compr_..> | 2018-06-20 13:13 | 21K | ||
PL_loratadina-compr_..> | 2018-06-20 13:13 | 25K | ||
PL_lisinopril-cyndea..> | 2018-06-20 13:13 | 33K | ||
PL_lisinopril-cyndea..> | 2018-06-20 13:13 | 37K | ||
PL_lexaprim-escitalo..> | 2018-06-20 13:13 | 107K | ||
PL_lexaprim-escitalo..> | 2018-06-20 13:13 | 111K | ||
PL_lansoprazol-lanso..> | 2018-06-20 13:13 | 32K | ||
PL_lansoprazol-lanso..> | 2018-06-20 13:13 | 36K | ||
PL_irbesartan-compr_..> | 2018-06-20 13:13 | 34K | ||
PL_ranitidina-raniti..> | 2018-06-20 13:12 | 21K | ||
PL_omeprazol-cinfame..> | 2018-06-20 13:12 | 41K | ||
PL_omeprazol-cinfame..> | 2018-06-20 13:12 | 45K | ||
PL_omeprazol-cinfa_P..> | 2018-06-20 13:12 | 99K | ||
PL_metformina-metfor..> | 2018-06-20 13:12 | 32K | ||
PL_metformina-metfor..> | 2018-06-20 13:12 | 36K | ||
PL_meloxicammeloxica..> | 2018-06-20 13:12 | 38K | ||
PL_ulcerbrex-rabepra..> | 2018-06-20 13:12 | 118K | ||
PL_tramadol_50mg.pdf | 2018-06-20 13:12 | 38K | ||
PL_tramadol_50mg-1.pdf | 2018-06-20 13:12 | 42K | ||
PL_simvastatina-simv..> | 2018-06-20 13:12 | 46K | ||
PL_simvastatina-simv..> | 2018-06-20 13:12 | 50K | ||
PL_sildenafilo-silde..> | 2018-06-20 13:12 | 54K | ||
PL_sildenafilo-silde..> | 2018-06-20 13:12 | 58K | ||
PL_respibien_05mg-ml..> | 2018-06-20 13:12 | 18K | ||
PL_respibien_05mg-ml..> | 2018-06-20 13:12 | 22K | ||
PL_ranitidina-raniti..> | 2018-06-20 13:12 | 17K | ||
Resfriado-int.-570x4..> | 2018-06-20 13:12 | 42K | ||
Resfriado-int.-539x3..> | 2018-06-20 13:12 | 24K | ||
Resfriado-int.-500x4..> | 2018-06-20 13:12 | 42K | ||
Resfriado-int.-500x3..> | 2018-06-20 13:12 | 27K | ||
Resfriado-int.-400x2..> | 2018-06-20 13:12 | 15K | ||
Resfriado-int.-345x1..> | 2018-06-20 13:12 | 12K | ||
Resfriado-int.-300x2..> | 2018-06-20 13:12 | 9.7K | ||
Resfriado-int.-150x1..> | 2018-06-20 13:12 | 6.0K | ||
PL_ulcerbrex-rabepra..> | 2018-06-20 13:12 | 114K | ||
SPC_Lisinopril-cinfa..> | 2018-06-20 13:12 | 109K | ||
SPC_Lisinopril-cinfa..> | 2018-06-20 13:12 | 113K | ||
SPC_Ibufen_400MG.pdf | 2018-06-20 13:12 | 83K | ||
SPC-diclofenaco-50mg..> | 2018-06-20 13:12 | 95K | ||
SPC-diclofenaco-50mg..> | 2018-06-20 13:12 | 99K | ||
Resfriado-int..jpg | 2018-06-20 13:12 | 43K | ||
Resfriado-int.-700x4..> | 2018-06-20 13:12 | 38K | ||
Resfriado-int.-600x4..> | 2018-06-20 13:12 | 43K | ||
SPC_atenolol-cinfa_1..> | 2018-06-20 13:12 | 36K | ||
SPC_amoxicilina_500-..> | 2018-06-20 13:12 | 28K | ||
SPC_amoxicilina_500-..> | 2018-06-20 13:12 | 32K | ||
SPC_amlodipino-cinfa..> | 2018-06-20 13:12 | 107K | ||
SPC_amlodipino-cinfa..> | 2018-06-20 13:12 | 111K | ||
SPC_ambroxol-jarabe_..> | 2018-06-20 13:12 | 14K | ||
SPC_ambroxol-jarabe_..> | 2018-06-20 13:12 | 18K | ||
SPC_ambroxol-jarabe_..> | 2018-06-20 13:12 | 14K | ||
SPC_atorvastatina.pdf | 2018-06-20 13:12 | 274K | ||
SPC_atorvastatina-1.pdf | 2018-06-20 13:12 | 278K | ||
SPC_atenolol-cinfa_1..> | 2018-06-20 13:12 | 36K | ||
SPC_atenolol-cinfa_1..> | 2018-06-20 13:12 | 40K | ||
SPC_captopril-compri..> | 2018-06-20 13:12 | 136K | ||
SPC_captopril-1.pdf | 2018-06-20 13:12 | 137K | ||
SPC_azitromicina_500..> | 2018-06-20 13:12 | 120K | ||
SPC_azitromicina_500..> | 2018-06-20 13:12 | 124K | ||
SPC_cinfalair-montel..> | 2018-06-20 13:12 | 127K | ||
SPC_cetirizina_10mg.pdf | 2018-06-20 13:12 | 87K | ||
SPC_cetirizina_10mg-..> | 2018-06-20 13:12 | 91K | ||
SPC_cetiricina-cynde..> | 2018-06-20 13:12 | 86K | ||
SPC_cetiricina-cynde..> | 2018-06-20 13:12 | 90K | ||
SPC_captopril.pdf | 2018-06-20 13:12 | 129K | ||
SPC_captopril-compri..> | 2018-06-20 13:12 | 128K | ||
SPC_clopidogrel-cinf..> | 2018-06-20 13:12 | 126K | ||
SPC_ciprofloxacino_5..> | 2018-06-20 13:12 | 52K | ||
SPC_ciprofloxacino_5..> | 2018-06-20 13:12 | 56K | ||
SPC_cinfatos-expecto..> | 2018-06-20 13:12 | 40K | ||
SPC_cinfatos-expecto..> | 2018-06-20 13:12 | 44K | ||
SPC_cinfalair_-4-mg.pdf | 2018-06-20 13:12 | 123K | ||
SPC_cinfalair-montel..> | 2018-06-20 13:12 | 124K | ||
SPC_cinfalair-montel..> | 2018-06-20 13:12 | 127K | ||
SPC_fluoxetina-compr..> | 2018-06-20 13:12 | 111K | ||
SPC_fluconazol-cinfa..> | 2018-06-20 13:12 | 70K | ||
SPC_enalapril_5-y-20..> | 2018-06-20 13:12 | 58K | ||
SPC_enalapril_5-y-20..> | 2018-06-20 13:12 | 62K | ||
SPC_diclofenaco_50mg..> | 2018-06-20 13:12 | 95K | ||
SPC_diclofenaco_50mg..> | 2018-06-20 13:12 | 99K | ||
SPC_diclofenaco-cynd..> | 2018-06-20 13:12 | 47K | ||
SPC_diclofenaco-cynd..> | 2018-06-20 13:12 | 51K | ||
SPC_cocinfaval-valsa..> | 2018-06-20 13:12 | 193K | ||
SPC_clopidogrel-cinf..> | 2018-06-20 13:12 | 122K | ||
SPC_furosemida-compr..> | 2018-06-20 13:12 | 124K | ||
SPC_fluoxetina-compr..> | 2018-06-20 13:12 | 107K | ||
SPC_fluconazol-cinfa..> | 2018-06-20 13:12 | 66K | ||
SPC_irbesartan-compr..> | 2018-06-20 13:12 | 132K | ||
SPC_irbesartan-compr..> | 2018-06-20 13:12 | 128K | ||
SPC_irbesartan-compr..> | 2018-06-20 13:12 | 132K | ||
SPC_garydol.pdf | 2018-06-20 13:12 | 12K | ||
SPC_garydol-1.pdf | 2018-06-20 13:12 | 16K | ||
SPC_furosemida-compr..> | 2018-06-20 13:12 | 120K | ||
SPC_loratadina-compr..> | 2018-06-20 13:12 | 30K | ||
SPC_lisinopril-cynde..> | 2018-06-20 13:12 | 110K | ||
SPC_lisinopril-cynde..> | 2018-06-20 13:12 | 114K | ||
SPC_lansoprazol-lans..> | 2018-06-20 13:12 | 106K | ||
SPC_lansoprazol-lans..> | 2018-06-20 13:12 | 110K | ||
SPC_irbesartan-compr..> | 2018-06-20 13:12 | 128K | ||
SPC_meloxicam-1.pdf | 2018-06-20 13:12 | 141K | ||
SPC_losartan-compr.pdf | 2018-06-20 13:12 | 108K | ||
SPC_losartan-compr-1..> | 2018-06-20 13:12 | 112K | ||
SPC_loratadina-compr..> | 2018-06-20 13:12 | 26K | ||
company_profile.pdf_Old | 2018-06-20 13:12 | 14M | ||
SPC_omeprazol-cinfa_..> | 2018-06-20 13:12 | 193K | ||
SPC_metformina.pdf | 2018-06-20 13:12 | 85K | ||
SPC_metformina-1.pdf | 2018-06-20 13:12 | 89K | ||
SPC_meloxicam.pdf | 2018-06-20 13:12 | 137K | ||
SPC_ranitidina-ranit..> | 2018-06-20 13:12 | 76K | ||
SPC_ranitidina-ranit..> | 2018-06-20 13:12 | 80K | ||
SPC_omeprazol-cinfam..> | 2018-06-20 13:12 | 37K | ||
SPC_omeprazol-cinfam..> | 2018-06-20 13:12 | 41K | ||
SPC_simvastatina-sim..> | 2018-06-20 13:12 | 97K | ||
SPC_sildenafilo-sild..> | 2018-06-20 13:12 | 98K | ||
SPC_sildenafilo-sild..> | 2018-06-20 13:12 | 102K | ||
SPC_respibien_05mg-m..> | 2018-06-20 13:12 | 26K | ||
SPC_respibien_05mg-m..> | 2018-06-20 13:12 | 30K | ||
SPC_tramadol_50mg.pdf | 2018-06-20 13:12 | 96K | ||
SPC_tramadol_50mg-1.pdf | 2018-06-20 13:12 | 100K | ||
SPC_simvastatina-sim..> | 2018-06-20 13:12 | 93K | ||
Sakura-2-500x363.jpg | 2018-06-20 13:12 | 41K | ||
Sakura-2-400x260.jpg | 2018-06-20 13:12 | 25K | ||
Sakura-2-345x198.jpg | 2018-06-20 13:12 | 18K | ||
Sakura-2-300x182.jpg | 2018-06-20 13:12 | 15K | ||
Sakura-2-150x150.jpg | 2018-06-20 13:12 | 7.4K | ||
Sakura-1.jpg | 2018-06-20 13:12 | 48K | ||
Sakura-1-150x150.jpg | 2018-06-20 13:12 | 4.0K | ||
SPC_ziquin-levofloxa..> | 2018-06-20 13:12 | 231K | ||
company_profile.pdf | 2018-06-20 13:12 | 13M | ||
areta-150x150.jpg | 2018-06-20 13:12 | 8.0K | ||
Sakura-2.jpg | 2018-06-20 13:12 | 48K | ||
Sakura-2-600x363.jpg | 2018-06-20 13:12 | 47K | ||
Sakura-2-570x363.jpg | 2018-06-20 13:12 | 45K | ||
Sakura-2-539x303.jpg | 2018-06-20 13:12 | 35K | ||
be-1-570x400.jpg | 2018-06-20 13:12 | 51K | ||
be-1-539x303.jpg | 2018-06-20 13:12 | 36K | ||
be-1-500x400.jpg | 2018-06-20 13:12 | 47K | ||
be-1-500x380.jpg | 2018-06-20 13:12 | 40K | ||
be-1-400x260.jpg | 2018-06-20 13:12 | 25K | ||
be-1-345x198.jpg | 2018-06-20 13:12 | 19K | ||
be-1-300x200.jpg | 2018-06-20 13:12 | 17K | ||
be-1-150x150.jpg | 2018-06-20 13:12 | 9.1K | ||
areta.jpg | 2018-06-20 13:12 | 74K | ||
areta-700x394.jpg | 2018-06-20 13:12 | 60K | ||
areta-600x407.jpg | 2018-06-20 13:12 | 61K | ||
areta-570x407.jpg | 2018-06-20 13:12 | 59K | ||
areta-539x303.jpg | 2018-06-20 13:12 | 38K | ||
areta-500x407.jpg | 2018-06-20 13:12 | 52K | ||
areta-500x380.jpg | 2018-06-20 13:12 | 45K | ||
areta-400x260.jpg | 2018-06-20 13:12 | 27K | ||
areta-345x198.jpg | 2018-06-20 13:12 | 19K | ||
areta-300x169.jpg | 2018-06-20 13:12 | 14K | ||
call-to-action-1024x..> | 2018-06-20 13:12 | 2.2K | ||
be.jpg | 2018-06-20 13:12 | 100K | ||
be-1024x162.jpg | 2018-06-20 13:12 | 34K | ||
be-1000x300.jpg | 2018-06-20 13:12 | 68K | ||
be-800x300.jpg | 2018-06-20 13:12 | 55K | ||
be-768x121.jpg | 2018-06-20 13:12 | 22K | ||
be-700x111.jpg | 2018-06-20 13:12 | 19K | ||
be-600x300.jpg | 2018-06-20 13:12 | 46K | ||
be-570x300.jpg | 2018-06-20 13:12 | 45K | ||
be-539x300.jpg | 2018-06-20 13:12 | 43K | ||
be-500x300.jpg | 2018-06-20 13:12 | 39K | ||
be-400x260.jpg | 2018-06-20 13:12 | 25K | ||
be-345x198.jpg | 2018-06-20 13:12 | 19K | ||
be-300x47.jpg | 2018-06-20 13:12 | 5.7K | ||
be-150x150.jpg | 2018-06-20 13:12 | 6.0K | ||
be-1.jpg | 2018-06-20 13:12 | 52K | ||
be-1-600x400.jpg | 2018-06-20 13:12 | 52K | ||
dossier-infarco-1920..> | 2018-06-20 13:12 | 3.3M | ||
degradado-1024x80.png | 2018-06-20 13:12 | 20K | ||
degradado-1000x150.png | 2018-06-20 13:12 | 28K | ||
degradado-570x150.png | 2018-06-20 13:12 | 16K | ||
degradado-539x150.png | 2018-06-20 13:12 | 15K | ||
degradado-500x150.png | 2018-06-20 13:12 | 14K | ||
degradado-400x150.png | 2018-06-20 13:12 | 11K | ||
degradado-345x150.png | 2018-06-20 13:12 | 9.7K | ||
degradado-300x150.png | 2018-06-20 13:12 | 8.3K | ||
degradado-300x23.png | 2018-06-20 13:12 | 3.9K | ||
degradado-150x150.png | 2018-06-20 13:12 | 4.6K | ||
cinfatos-es-spc.pdf | 2018-06-20 13:12 | 39K | ||
cinfatos-es-pl.pdf | 2018-06-20 13:12 | 33K | ||
cinfa.png | 2018-06-20 13:12 | 2.6K | ||
cinfa-alt.png | 2018-06-20 13:12 | 2.0K | ||
cinfa-150x55.png | 2018-06-20 13:12 | 1.8K | ||
call-to-action.jpg | 2018-06-20 13:12 | 14K | ||
call-to-action-1000x..> | 2018-06-20 13:12 | 3.4K | ||
call-to-action-800x1..> | 2018-06-20 13:12 | 2.9K | ||
call-to-action-768x6..> | 2018-06-20 13:12 | 1.6K | ||
call-to-action-700x5..> | 2018-06-20 13:12 | 1.5K | ||
call-to-action-630x1..> | 2018-06-20 13:12 | 2.4K | ||
call-to-action-600x1..> | 2018-06-20 13:12 | 2.3K | ||
call-to-action-570x1..> | 2018-06-20 13:12 | 2.3K | ||
call-to-action-539x1..> | 2018-06-20 13:12 | 2.2K | ||
call-to-action-500x1..> | 2018-06-20 13:12 | 2.1K | ||
call-to-action-400x1..> | 2018-06-20 13:12 | 1.8K | ||
call-to-action-345x1..> | 2018-06-20 13:12 | 1.6K | ||
call-to-action-300x1..> | 2018-06-20 13:12 | 1.5K | ||
call-to-action-300x2..> | 2018-06-20 13:12 | 921 | ||
call-to-action-150x1..> | 2018-06-20 13:12 | 1.1K | ||
farmalastic-1-150x15..> | 2018-06-20 13:12 | 9.3K | ||
ethical-345x198.jpg | 2018-06-20 13:12 | 16K | ||
ethical-300x300.jpg | 2018-06-20 13:12 | 21K | ||
ethical-150x150.jpg | 2018-06-20 13:12 | 7.6K | ||
es-spc.pdf | 2018-06-20 13:12 | 71K | ||
es-pl.pdf | 2018-06-20 13:12 | 40K | ||
environment.jpg | 2018-06-20 13:12 | 84K | ||
environment-500x500.jpg | 2018-06-20 13:12 | 83K | ||
environment-500x380.jpg | 2018-06-20 13:12 | 73K | ||
environment-500x303.jpg | 2018-06-20 13:12 | 63K | ||
environment-400x260.jpg | 2018-06-20 13:12 | 39K | ||
environment-345x198.jpg | 2018-06-20 13:12 | 27K | ||
environment-300x300.jpg | 2018-06-20 13:12 | 29K | ||
environment-150x150.jpg | 2018-06-20 13:12 | 8.2K | ||
dossier-infarco-1920..> | 2018-06-20 13:12 | 97K | ||
dossier-infarco-1920..> | 2018-06-20 13:12 | 15K | ||
dossier-infarco-1920..> | 2018-06-20 13:12 | 4.7K | ||
degradado.png | 2018-06-20 13:12 | 41K | ||
degradado-800x150.png | 2018-06-20 13:12 | 22K | ||
degradado-768x60.png | 2018-06-20 13:12 | 13K | ||
degradado-700x55.png | 2018-06-20 13:12 | 24K | ||
degradado-630x150.png | 2018-06-20 13:12 | 17K | ||
degradado-600x150.png | 2018-06-20 13:12 | 16K | ||
farmalastic-1-300x20..> | 2018-06-20 13:12 | 16K | ||
ethical.jpg | 2018-06-20 13:12 | 55K | ||
ethical-500x500.jpg | 2018-06-20 13:12 | 54K | ||
ethical-500x380.jpg | 2018-06-20 13:12 | 41K | ||
ethical-500x303.jpg | 2018-06-20 13:12 | 32K | ||
ethical-400x260.jpg | 2018-06-20 13:12 | 22K | ||
furosemida-es-pl.pdf | 2018-06-20 13:12 | 58K | ||
farmalastic.jpg | 2018-06-20 13:12 | 76K | ||
farmalastic-1024x162..> | 2018-06-20 13:12 | 24K | ||
farmalastic-1000x300..> | 2018-06-20 13:12 | 52K | ||
farmalastic-600x300.jpg | 2018-06-20 13:12 | 30K | ||
farmalastic-570x300.jpg | 2018-06-20 13:12 | 27K | ||
farmalastic-539x300.jpg | 2018-06-20 13:12 | 25K | ||
farmalastic-500x300.jpg | 2018-06-20 13:12 | 23K | ||
farmalastic-400x260.jpg | 2018-06-20 13:12 | 15K | ||
farmalastic-345x198.jpg | 2018-06-20 13:12 | 11K | ||
farmalastic-300x47.jpg | 2018-06-20 13:12 | 4.2K | ||
farmalastic-150x150.jpg | 2018-06-20 13:12 | 3.9K | ||
farmalastic-1.jpg | 2018-06-20 13:12 | 51K | ||
farmalastic-1-600x40..> | 2018-06-20 13:12 | 52K | ||
farmalastic-1-570x40..> | 2018-06-20 13:12 | 50K | ||
farmalastic-1-539x30..> | 2018-06-20 13:12 | 35K | ||
farmalastic-1-500x40..> | 2018-06-20 13:12 | 49K | ||
farmalastic-1-500x38..> | 2018-06-20 13:12 | 40K | ||
farmalastic-1-400x26..> | 2018-06-20 13:12 | 25K | ||
farmalastic-1-345x19..> | 2018-06-20 13:12 | 18K | ||
genricos-1024x162.jpg | 2018-06-20 13:12 | 31K | ||
genricos-1000x300.jpg | 2018-06-20 13:12 | 47K | ||
genricos-768x121.jpg | 2018-06-20 13:12 | 20K | ||
genricos-400x260.jpg | 2018-06-20 13:12 | 21K | ||
genricos-345x198.jpg | 2018-06-20 13:12 | 15K | ||
genricos-300x47.jpg | 2018-06-20 13:12 | 5.3K | ||
genricos-150x150.jpg | 2018-06-20 13:12 | 8.2K | ||
genericos.jpg | 2018-06-20 13:12 | 53K | ||
genericos-600x400.jpg | 2018-06-20 13:12 | 53K | ||
genericos-570x400.jpg | 2018-06-20 13:12 | 51K | ||
genericos-539x303.jpg | 2018-06-20 13:12 | 36K | ||
genericos-500x400.jpg | 2018-06-20 13:12 | 48K | ||
genericos-500x380.jpg | 2018-06-20 13:12 | 42K | ||
genericos-400x260.jpg | 2018-06-20 13:12 | 26K | ||
genericos-345x198.jpg | 2018-06-20 13:12 | 20K | ||
genericos-300x200.jpg | 2018-06-20 13:12 | 17K | ||
genericos-150x150.jpg | 2018-06-20 13:12 | 9.2K | ||
furosemida-es-spc.pdf | 2018-06-20 13:12 | 79K | ||
footer-logo.png | 2018-06-20 13:12 | 345 | ||
favicon.png | 2018-06-20 13:12 | 1.6K | ||
favicon-1.png | 2018-06-20 13:12 | 1.6K | ||
farmalastic-800x300.jpg | 2018-06-20 13:12 | 43K | ||
farmalastic-768x121.jpg | 2018-06-20 13:12 | 15K | ||
farmalastic-700x111.jpg | 2018-06-20 13:12 | 13K | ||
header-genericos-100..> | 2018-06-20 13:12 | 33K | ||
header-genericos-100..> | 2018-06-20 13:12 | 29K | ||
header-genericos-500..> | 2018-06-20 13:12 | 16K | ||
header-genericos-100..> | 2018-06-20 13:12 | 2.3K | ||
header-familia.jpg | 2018-06-20 13:12 | 67K | ||
header-familia-1024x..> | 2018-06-20 13:12 | 23K | ||
header-familia-1000x..> | 2018-06-20 13:12 | 35K | ||
header-familia-800x3..> | 2018-06-20 13:12 | 27K | ||
header-familia-768x1..> | 2018-06-20 13:12 | 14K | ||
header-familia-700x1..> | 2018-06-20 13:12 | 12K | ||
header-familia-600x3..> | 2018-06-20 13:12 | 22K | ||
header-familia-570x3..> | 2018-06-20 13:12 | 21K | ||
header-familia-539x3..> | 2018-06-20 13:12 | 20K | ||
header-familia-500x3..> | 2018-06-20 13:12 | 19K | ||
header-familia-400x2..> | 2018-06-20 13:12 | 12K | ||
header-familia-345x1..> | 2018-06-20 13:12 | 9.8K | ||
header-familia-300x4..> | 2018-06-20 13:12 | 3.9K | ||
header-familia-150x1..> | 2018-06-20 13:12 | 3.6K | ||
genricos.jpg | 2018-06-20 13:12 | 88K | ||
genricos-800x300.jpg | 2018-06-20 13:12 | 38K | ||
genricos-700x111.jpg | 2018-06-20 13:12 | 17K | ||
genricos-600x300.jpg | 2018-06-20 13:12 | 32K | ||
genricos-570x300.jpg | 2018-06-20 13:12 | 31K | ||
genricos-539x300.jpg | 2018-06-20 13:12 | 30K | ||
genricos-500x300.jpg | 2018-06-20 13:12 | 30K | ||
header-nina-1024x162..> | 2018-06-20 13:12 | 79K | ||
header-nina-1000x300..> | 2018-06-20 13:12 | 111K | ||
header-nina-539x300.jpg | 2018-06-20 13:12 | 65K | ||
header-nina-500x300.jpg | 2018-06-20 13:12 | 60K | ||
header-nina-400x260.jpg | 2018-06-20 13:12 | 43K | ||
header-nina-345x198.jpg | 2018-06-20 13:12 | 31K | ||
header-nina-300x47.jpg | 2018-06-20 13:12 | 8.5K | ||
header-nina-150x150.jpg | 2018-06-20 13:12 | 12K | ||
header-lpless.jpg | 2018-06-20 13:12 | 84K | ||
header-lpless-1024x1..> | 2018-06-20 13:12 | 30K | ||
header-lpless-1000x3..> | 2018-06-20 13:12 | 63K | ||
header-lpless-800x30..> | 2018-06-20 13:12 | 52K | ||
header-lpless-768x12..> | 2018-06-20 13:12 | 19K | ||
header-lpless-700x11..> | 2018-06-20 13:12 | 16K | ||
header-lpless-600x30..> | 2018-06-20 13:12 | 40K | ||
header-lpless-570x30..> | 2018-06-20 13:12 | 38K | ||
header-lpless-539x30..> | 2018-06-20 13:12 | 36K | ||
header-lpless-500x30..> | 2018-06-20 13:12 | 34K | ||
header-lpless-400x26..> | 2018-06-20 13:12 | 22K | ||
header-lpless-345x19..> | 2018-06-20 13:12 | 17K | ||
header-lpless-300x47..> | 2018-06-20 13:12 | 5.1K | ||
header-lpless-150x15..> | 2018-06-20 13:12 | 6.9K | ||
header-genericos.jpg | 2018-06-20 13:12 | 79K | ||
header-genericos-102..> | 2018-06-20 13:12 | 24K | ||
header-genericos-800..> | 2018-06-20 13:12 | 27K | ||
header-genericos-768..> | 2018-06-20 13:12 | 16K | ||
header-genericos-700..> | 2018-06-20 13:12 | 14K | ||
header-genericos-630..> | 2018-06-20 13:12 | 15K | ||
header-genericos-600..> | 2018-06-20 13:12 | 21K | ||
header-genericos-570..> | 2018-06-20 13:12 | 19K | ||
header-genericos-539..> | 2018-06-20 13:12 | 13K | ||
header-genericos-500..> | 2018-06-20 13:12 | 18K | ||
header-genericos-500..> | 2018-06-20 13:12 | 14K | ||
header-genericos-400..> | 2018-06-20 13:12 | 9.6K | ||
header-genericos-345..> | 2018-06-20 13:12 | 7.5K | ||
header-genericos-300..> | 2018-06-20 13:12 | 7.5K | ||
header-genericos-300..> | 2018-06-20 13:12 | 4.6K | ||
header-genericos-150..> | 2018-06-20 13:12 | 3.4K | ||
header_laboratorio.jpg | 2018-06-20 13:12 | 147K | ||
header_laboratorio-1..> | 2018-06-20 13:12 | 69K | ||
header_laboratorio-1..> | 2018-06-20 13:12 | 88K | ||
header_laboratorio-1..> | 2018-06-20 13:12 | 67K | ||
header_laboratorio-3..> | 2018-06-20 13:12 | 17K | ||
header_laboratorio-1..> | 2018-06-20 13:12 | 6.9K | ||
header_compromiso.jpg | 2018-06-20 13:12 | 140K | ||
header_compromiso-10..> | 2018-06-20 13:12 | 35K | ||
header_compromiso-10..> | 2018-06-20 13:12 | 48K | ||
header_compromiso-10..> | 2018-06-20 13:12 | 34K | ||
header_compromiso-80..> | 2018-06-20 13:12 | 33K | ||
header_compromiso-76..> | 2018-06-20 13:12 | 23K | ||
header_compromiso-70..> | 2018-06-20 13:12 | 20K | ||
header_compromiso-63..> | 2018-06-20 13:12 | 17K | ||
header_compromiso-60..> | 2018-06-20 13:12 | 31K | ||
header_compromiso-57..> | 2018-06-20 13:12 | 24K | ||
header_compromiso-53..> | 2018-06-20 13:12 | 15K | ||
header_compromiso-50..> | 2018-06-20 13:12 | 27K | ||
header_compromiso-50..> | 2018-06-20 13:12 | 20K | ||
header_compromiso-50..> | 2018-06-20 13:12 | 17K | ||
header_compromiso-40..> | 2018-06-20 13:12 | 11K | ||
header_compromiso-34..> | 2018-06-20 13:12 | 8.6K | ||
header_compromiso-30..> | 2018-06-20 13:12 | 8.9K | ||
header_compromiso-30..> | 2018-06-20 13:12 | 6.5K | ||
header_compromiso-15..> | 2018-06-20 13:12 | 4.2K | ||
header-nina.jpg | 2018-06-20 13:12 | 226K | ||
header-nina-800x300.jpg | 2018-06-20 13:12 | 91K | ||
header-nina-768x121.jpg | 2018-06-20 13:12 | 47K | ||
header-nina-700x111.jpg | 2018-06-20 13:12 | 39K | ||
header-nina-600x300.jpg | 2018-06-20 13:12 | 71K | ||
header-nina-570x300.jpg | 2018-06-20 13:12 | 68K | ||
header_plantas-1000x..> | 2018-06-20 13:11 | 71K | ||
header_plantas-1000x..> | 2018-06-20 13:11 | 59K | ||
header_lincesing.jpg | 2018-06-20 13:11 | 186K | ||
header_lincesing-102..> | 2018-06-20 13:11 | 50K | ||
header_lincesing-100..> | 2018-06-20 13:11 | 64K | ||
header_lincesing-100..> | 2018-06-20 13:11 | 56K | ||
header_lincesing-800..> | 2018-06-20 13:11 | 46K | ||
header_lincesing-768..> | 2018-06-20 13:11 | 32K | ||
header_lincesing-700..> | 2018-06-20 13:11 | 27K | ||
header_lincesing-630..> | 2018-06-20 13:11 | 27K | ||
header_lincesing-600..> | 2018-06-20 13:11 | 33K | ||
header_lincesing-570..> | 2018-06-20 13:11 | 29K | ||
header_lincesing-539..> | 2018-06-20 13:11 | 23K | ||
header_lincesing-500..> | 2018-06-20 13:11 | 27K | ||
header_lincesing-500..> | 2018-06-20 13:11 | 24K | ||
header_lincesing-500..> | 2018-06-20 13:11 | 22K | ||
header_lincesing-400..> | 2018-06-20 13:11 | 15K | ||
header_lincesing-345..> | 2018-06-20 13:11 | 11K | ||
header_lincesing-300..> | 2018-06-20 13:11 | 9.7K | ||
header_lincesing-300..> | 2018-06-20 13:11 | 7.2K | ||
header_lincesing-150..> | 2018-06-20 13:11 | 3.8K | ||
header_laboratorio-8..> | 2018-06-20 13:11 | 61K | ||
header_laboratorio-7..> | 2018-06-20 13:11 | 46K | ||
header_laboratorio-7..> | 2018-06-20 13:11 | 40K | ||
header_laboratorio-6..> | 2018-06-20 13:11 | 34K | ||
header_laboratorio-6..> | 2018-06-20 13:11 | 53K | ||
header_laboratorio-5..> | 2018-06-20 13:11 | 44K | ||
header_laboratorio-5..> | 2018-06-20 13:11 | 31K | ||
header_laboratorio-5..> | 2018-06-20 13:11 | 46K | ||
header_laboratorio-5..> | 2018-06-20 13:11 | 36K | ||
header_laboratorio-5..> | 2018-06-20 13:11 | 32K | ||
header_laboratorio-4..> | 2018-06-20 13:11 | 22K | ||
header_laboratorio-3..> | 2018-06-20 13:11 | 16K | ||
header_laboratorio-3..> | 2018-06-20 13:11 | 12K | ||
header_valores-1024x..> | 2018-06-20 13:11 | 26K | ||
header_valores-1000x..> | 2018-06-20 13:11 | 44K | ||
header_valores-1000x..> | 2018-06-20 13:11 | 26K | ||
header_valores-570x5..> | 2018-06-20 13:11 | 24K | ||
header_valores-500x7..> | 2018-06-20 13:11 | 31K | ||
header_valores-345x1..> | 2018-06-20 13:11 | 6.6K | ||
header_valores-300x2..> | 2018-06-20 13:11 | 7.7K | ||
header_valores-300x1..> | 2018-06-20 13:11 | 4.8K | ||
header_valores-150x1..> | 2018-06-20 13:11 | 4.1K | ||
header_plantas.jpg | 2018-06-20 13:11 | 219K | ||
header_plantas-1024x..> | 2018-06-20 13:11 | 53K | ||
header_plantas-800x5..> | 2018-06-20 13:11 | 57K | ||
header_plantas-768x2..> | 2018-06-20 13:11 | 33K | ||
header_plantas-700x2..> | 2018-06-20 13:11 | 28K | ||
header_plantas-630x3..> | 2018-06-20 13:11 | 27K | ||
header_plantas-600x5..> | 2018-06-20 13:11 | 43K | ||
header_plantas-570x5..> | 2018-06-20 13:11 | 36K | ||
header_plantas-539x3..> | 2018-06-20 13:11 | 23K | ||
header_plantas-500x5..> | 2018-06-20 13:11 | 36K | ||
header_plantas-500x5..> | 2018-06-20 13:11 | 30K | ||
header_plantas-500x3..> | 2018-06-20 13:11 | 25K | ||
header_plantas-400x2..> | 2018-06-20 13:11 | 16K | ||
header_plantas-345x1..> | 2018-06-20 13:11 | 12K | ||
header_plantas-300x2..> | 2018-06-20 13:11 | 12K | ||
header_plantas-300x1..> | 2018-06-20 13:11 | 7.6K | ||
header_plantas-150x1..> | 2018-06-20 13:11 | 4.7K | ||
irbesartan-es-spc.pdf | 2018-06-20 13:11 | 85K | ||
icon-lincesing-out.jpg | 2018-06-20 13:11 | 1.7K | ||
header_vanguardia.jpg | 2018-06-20 13:11 | 243K | ||
header_vanguardia-10..> | 2018-06-20 13:11 | 96K | ||
header_vanguardia-10..> | 2018-06-20 13:11 | 146K | ||
header_vanguardia-10..> | 2018-06-20 13:11 | 94K | ||
header_vanguardia-80..> | 2018-06-20 13:11 | 93K | ||
header_vanguardia-76..> | 2018-06-20 13:11 | 60K | ||
header_vanguardia-70..> | 2018-06-20 13:11 | 52K | ||
header_vanguardia-63..> | 2018-06-20 13:11 | 42K | ||
header_vanguardia-60..> | 2018-06-20 13:11 | 95K | ||
header_vanguardia-57..> | 2018-06-20 13:11 | 67K | ||
header_vanguardia-53..> | 2018-06-20 13:11 | 38K | ||
header_vanguardia-50..> | 2018-06-20 13:11 | 79K | ||
header_vanguardia-50..> | 2018-06-20 13:11 | 55K | ||
header_vanguardia-50..> | 2018-06-20 13:11 | 45K | ||
header_vanguardia-40..> | 2018-06-20 13:11 | 27K | ||
header_vanguardia-34..> | 2018-06-20 13:11 | 19K | ||
header_vanguardia-30..> | 2018-06-20 13:11 | 20K | ||
header_vanguardia-30..> | 2018-06-20 13:11 | 13K | ||
header_vanguardia-15..> | 2018-06-20 13:11 | 7.8K | ||
header_valores.jpg | 2018-06-20 13:11 | 94K | ||
header_valores-800x6..> | 2018-06-20 13:11 | 29K | ||
header_valores-768x3..> | 2018-06-20 13:11 | 17K | ||
header_valores-700x3..> | 2018-06-20 13:11 | 15K | ||
header_valores-630x3..> | 2018-06-20 13:11 | 13K | ||
header_valores-600x7..> | 2018-06-20 13:11 | 34K | ||
header_valores-539x3..> | 2018-06-20 13:11 | 12K | ||
header_valores-500x5..> | 2018-06-20 13:11 | 20K | ||
header_valores-500x3..> | 2018-06-20 13:11 | 15K | ||
header_valores-400x2..> | 2018-06-20 13:11 | 9.1K | ||
planta_huarte-239x19..> | 2018-06-20 13:11 | 10K | ||
olloki-700x394.jpg | 2018-06-20 13:11 | 63K | ||
olloki-570x407.jpg | 2018-06-20 13:11 | 62K | ||
olloki-500x407.jpg | 2018-06-20 13:11 | 54K | ||
olloki-500x380.jpg | 2018-06-20 13:11 | 46K | ||
olloki-400x260.jpg | 2018-06-20 13:11 | 27K | ||
olloki-345x198.jpg | 2018-06-20 13:11 | 19K | ||
olloki-300x169.jpg | 2018-06-20 13:11 | 14K | ||
olloki-150x150.jpg | 2018-06-20 13:11 | 7.6K | ||
ns.jpg | 2018-06-20 13:11 | 89K | ||
ns-1024x162.jpg | 2018-06-20 13:11 | 30K | ||
ns-1000x300.jpg | 2018-06-20 13:11 | 62K | ||
ns-800x300.jpg | 2018-06-20 13:11 | 45K | ||
ns-768x121.jpg | 2018-06-20 13:11 | 19K | ||
ns-700x111.jpg | 2018-06-20 13:11 | 17K | ||
ns-600x300.jpg | 2018-06-20 13:11 | 33K | ||
ns-570x300.jpg | 2018-06-20 13:11 | 31K | ||
ns-539x300.jpg | 2018-06-20 13:11 | 29K | ||
ns-500x300.jpg | 2018-06-20 13:11 | 27K | ||
ns-400x260.jpg | 2018-06-20 13:11 | 18K | ||
ns-345x198.jpg | 2018-06-20 13:11 | 13K | ||
ns-300x47.jpg | 2018-06-20 13:11 | 5.1K | ||
ns-150x150.jpg | 2018-06-20 13:11 | 5.5K | ||
ns-1.jpg | 2018-06-20 13:11 | 58K | ||
ns-1-600x400.jpg | 2018-06-20 13:11 | 58K | ||
ns-1-570x400.jpg | 2018-06-20 13:11 | 57K | ||
ns-1-539x303.jpg | 2018-06-20 13:11 | 40K | ||
ns-1-500x400.jpg | 2018-06-20 13:11 | 56K | ||
ns-1-500x380.jpg | 2018-06-20 13:11 | 46K | ||
ns-1-400x260.jpg | 2018-06-20 13:11 | 28K | ||
ns-1-345x198.jpg | 2018-06-20 13:11 | 21K | ||
ns-1-300x200.jpg | 2018-06-20 13:11 | 18K | ||
ns-1-150x150.jpg | 2018-06-20 13:11 | 10K | ||
lateral-menu2.png | 2018-06-20 13:11 | 1.0K | ||
lateral-menu.png | 2018-06-20 13:11 | 1.0K | ||
irbesartan-es-pl.pdf | 2018-06-20 13:11 | 30K | ||
icon-products.jpg | 2018-06-20 13:11 | 17K | ||
icon-lab-cinfa.png | 2018-06-20 13:11 | 2.6K | ||
resfriado-1024x162.jpg | 2018-06-20 13:11 | 37K | ||
resfriado-1000x300.jpg | 2018-06-20 13:11 | 50K | ||
resfriado-300x47.jpg | 2018-06-20 13:11 | 6.0K | ||
resfriado-1.jpg | 2018-06-20 13:11 | 53K | ||
resfriado-1-600x400.jpg | 2018-06-20 13:11 | 54K | ||
resfriado-1-570x400.jpg | 2018-06-20 13:11 | 52K | ||
resfriado-1-539x303.jpg | 2018-06-20 13:11 | 36K | ||
resfriado-1-500x400.jpg | 2018-06-20 13:11 | 47K | ||
resfriado-1-500x380.jpg | 2018-06-20 13:11 | 40K | ||
resfriado-1-400x260.jpg | 2018-06-20 13:11 | 25K | ||
resfriado-1-345x198.jpg | 2018-06-20 13:11 | 19K | ||
resfriado-1-300x200.jpg | 2018-06-20 13:11 | 16K | ||
resfriado-1-150x150.jpg | 2018-06-20 13:11 | 8.4K | ||
planta_olloki.jpg | 2018-06-20 13:11 | 55K | ||
planta_olloki-239x38..> | 2018-06-20 13:11 | 22K | ||
planta_olloki-239x30..> | 2018-06-20 13:11 | 18K | ||
planta_olloki-239x30..> | 2018-06-20 13:11 | 18K | ||
planta_olloki-239x26..> | 2018-06-20 13:11 | 16K | ||
planta_olloki-239x24..> | 2018-06-20 13:11 | 14K | ||
planta_olloki-239x19..> | 2018-06-20 13:11 | 12K | ||
planta_olloki-155x30..> | 2018-06-20 13:11 | 13K | ||
planta_olloki-150x15..> | 2018-06-20 13:11 | 7.0K | ||
planta_huarte.jpg | 2018-06-20 13:11 | 42K | ||
planta_huarte-239x30..> | 2018-06-20 13:11 | 14K | ||
planta_huarte-239x30..> | 2018-06-20 13:11 | 14K | ||
planta_huarte-239x26..> | 2018-06-20 13:11 | 13K | ||
planta_huarte-239x24..> | 2018-06-20 13:11 | 12K | ||
planta_huarte-230x30..> | 2018-06-20 13:11 | 13K | ||
planta_huarte-150x15..> | 2018-06-20 13:11 | 5.9K | ||
pin.png | 2018-06-20 13:11 | 2.9K | ||
olloki.jpg | 2018-06-20 13:11 | 79K | ||
olloki-600x407.jpg | 2018-06-20 13:11 | 64K | ||
olloki-539x303.jpg | 2018-06-20 13:11 | 40K | ||
slide-2-1-345x198.jpg | 2018-06-20 13:11 | 12K | ||
slide-1-1-1024x724.jpg | 2018-06-20 13:11 | 62K | ||
slide-1-1-1000x1000.jpg | 2018-06-20 13:11 | 81K | ||
slide-1-1-1000x500.jpg | 2018-06-20 13:11 | 42K | ||
sante.jpg | 2018-06-20 13:11 | 39K | ||
sante-600x363.jpg | 2018-06-20 13:11 | 38K | ||
sante-570x363.jpg | 2018-06-20 13:11 | 36K | ||
sante-539x303.jpg | 2018-06-20 13:11 | 30K | ||
sante-500x363.jpg | 2018-06-20 13:11 | 33K | ||
sante-400x260.jpg | 2018-06-20 13:11 | 22K | ||
sante-345x198.jpg | 2018-06-20 13:11 | 17K | ||
sante-300x182.jpg | 2018-06-20 13:11 | 14K | ||
sante-150x150.jpg | 2018-06-20 13:11 | 7.3K | ||
sakura-600x363.jpg | 2018-06-20 13:11 | 42K | ||
sakura-539x303.jpg | 2018-06-20 13:11 | 34K | ||
sakura-500x363.jpg | 2018-06-20 13:11 | 38K | ||
sakura-400x260.jpg | 2018-06-20 13:11 | 24K | ||
sakura-345x198.jpg | 2018-06-20 13:11 | 18K | ||
resfriado.jpg | 2018-06-20 13:11 | 113K | ||
resfriado-800x300.jpg | 2018-06-20 13:11 | 42K | ||
resfriado-768x121.jpg | 2018-06-20 13:11 | 24K | ||
resfriado-700x111.jpg | 2018-06-20 13:11 | 20K | ||
resfriado-600x300.jpg | 2018-06-20 13:11 | 30K | ||
resfriado-570x300.jpg | 2018-06-20 13:11 | 28K | ||
resfriado-539x300.jpg | 2018-06-20 13:11 | 25K | ||
resfriado-500x300.jpg | 2018-06-20 13:11 | 23K | ||
resfriado-400x260.jpg | 2018-06-20 13:11 | 13K | ||
resfriado-345x198.jpg | 2018-06-20 13:11 | 11K | ||
resfriado-150x150.jpg | 2018-06-20 13:11 | 2.8K | ||
slide-3-1-1024x680.jpg | 2018-06-20 13:11 | 112K | ||
slide-3-1-1000x797.jpg | 2018-06-20 13:11 | 125K | ||
slide-3-1-1000x500.jpg | 2018-06-20 13:11 | 88K | ||
slide-3-1-300x199.jpg | 2018-06-20 13:11 | 17K | ||
slide-2-1.jpg | 2018-06-20 13:11 | 65K | ||
slide-2-1-1024x397.jpg | 2018-06-20 13:11 | 46K | ||
slide-2-1-1000x582.jpg | 2018-06-20 13:11 | 58K | ||
slide-2-1-1000x500.jpg | 2018-06-20 13:11 | 53K | ||
slide-2-1-800x582.jpg | 2018-06-20 13:11 | 48K | ||
slide-2-1-768x298.jpg | 2018-06-20 13:11 | 30K | ||
slide-2-1-700x272.jpg | 2018-06-20 13:11 | 26K | ||
slide-2-1-630x300.jpg | 2018-06-20 13:11 | 26K | ||
slide-2-1-600x582.jpg | 2018-06-20 13:11 | 36K | ||
slide-2-1-570x570.jpg | 2018-06-20 13:11 | 35K | ||
slide-2-1-539x303.jpg | 2018-06-20 13:11 | 23K | ||
slide-2-1-500x582.jpg | 2018-06-20 13:11 | 28K | ||
slide-2-1-500x500.jpg | 2018-06-20 13:11 | 29K | ||
slide-2-1-500x380.jpg | 2018-06-20 13:11 | 26K | ||
slide-2-1-400x260.jpg | 2018-06-20 13:11 | 17K | ||
slide-2-1-300x240.jpg | 2018-06-20 13:11 | 13K | ||
slide-2-1-300x116.jpg | 2018-06-20 13:11 | 7.6K | ||
slide-2-1-150x150.jpg | 2018-06-20 13:11 | 5.6K | ||
slide-2-1-100x50.jpg | 2018-06-20 13:11 | 15K | ||
slide-1.jpg | 2018-06-20 13:11 | 71K | ||
slide-1-1.jpg | 2018-06-20 13:11 | 82K | ||
slide-1-1-800x600.jpg | 2018-06-20 13:11 | 44K | ||
slide-1-1-768x543.jpg | 2018-06-20 13:11 | 39K | ||
slide-1-1-700x495.jpg | 2018-06-20 13:11 | 33K | ||
slide-1-1-630x300.jpg | 2018-06-20 13:11 | 19K | ||
slide-1-1-600x800.jpg | 2018-06-20 13:11 | 45K | ||
slide-1-1-570x570.jpg | 2018-06-20 13:11 | 33K | ||
slide-1-1-539x303.jpg | 2018-06-20 13:11 | 17K | ||
slide-1-1-500x1000.jpg | 2018-06-20 13:11 | 44K | ||
slide-1-1-500x500.jpg | 2018-06-20 13:11 | 27K | ||
slide-1-1-500x380.jpg | 2018-06-20 13:11 | 21K | ||
slide-1-1-400x260.jpg | 2018-06-20 13:11 | 13K | ||
slide-1-1-345x198.jpg | 2018-06-20 13:11 | 9.1K | ||
slide-1-1-300x240.jpg | 2018-06-20 13:11 | 9.6K | ||
slide-1-1-300x212.jpg | 2018-06-20 13:11 | 8.9K | ||
slide-1-1-150x150.jpg | 2018-06-20 13:11 | 4.5K | ||
teaming.jpg | 2018-06-20 13:11 | 65K | ||
teaming-500x500.jpg | 2018-06-20 13:11 | 65K | ||
teaming-500x380.jpg | 2018-06-20 13:11 | 54K | ||
teaming-500x303.jpg | 2018-06-20 13:11 | 46K | ||
teaming-400x260.jpg | 2018-06-20 13:11 | 31K | ||
teaming-345x198.jpg | 2018-06-20 13:11 | 23K | ||
teaming-300x300.jpg | 2018-06-20 13:11 | 26K | ||
teaming-150x150.jpg | 2018-06-20 13:11 | 8.8K | ||
social.jpg | 2018-06-20 13:11 | 58K | ||
social-500x500.jpg | 2018-06-20 13:11 | 58K | ||
social-500x380.jpg | 2018-06-20 13:11 | 49K | ||
social-500x303.jpg | 2018-06-20 13:11 | 42K | ||
social-400x260.jpg | 2018-06-20 13:11 | 29K | ||
social-345x198.jpg | 2018-06-20 13:11 | 22K | ||
social-300x300.jpg | 2018-06-20 13:11 | 25K | ||
social-150x150.jpg | 2018-06-20 13:11 | 9.2K | ||
slide-3-1.jpg | 2018-06-20 13:11 | 130K | ||
slide-3-1-800x600.jpg | 2018-06-20 13:11 | 84K | ||
slide-3-1-768x510.jpg | 2018-06-20 13:11 | 73K | ||
slide-3-1-700x465.jpg | 2018-06-20 13:11 | 64K | ||
slide-3-1-630x300.jpg | 2018-06-20 13:11 | 42K | ||
slide-3-1-600x797.jpg | 2018-06-20 13:11 | 82K | ||
slide-3-1-570x570.jpg | 2018-06-20 13:11 | 62K | ||
slide-3-1-539x303.jpg | 2018-06-20 13:11 | 37K | ||
slide-3-1-500x797.jpg | 2018-06-20 13:11 | 70K | ||
slide-3-1-500x500.jpg | 2018-06-20 13:11 | 51K | ||
slide-3-1-500x380.jpg | 2018-06-20 13:11 | 42K | ||
slide-3-1-400x260.jpg | 2018-06-20 13:11 | 26K | ||
slide-3-1-345x198.jpg | 2018-06-20 13:11 | 19K | ||
slide-3-1-300x240.jpg | 2018-06-20 13:11 | 19K | ||
slide-3-1-150x150.jpg | 2018-06-20 13:11 | 7.7K | ||